Setiausaha Agung NATO beri amaran Rusia mungkin sasar anggota perikatan seterusnya di tengah ketegangan meningkat kewangan

Setiausaha Agung NATO beri amaran Rusia mungkin sasar anggota perikatan seterusnya di tengah ketegangan meningkat

Disember 11, 2025
(SeaPRwire) - Jeneral-sektur NATO Mark Rutte memberi amaran kepada ahli-ahli gabungan transatlantik pada Khamis bahawa mereka mungkin menjadi sasaran seterusnya Rusia.Rutte, di Perwakilan Negeri Bavaria, yang diadakan oleh Konferens Keselamatan Munich di Jerman, mengingatkan malam tebing Berlin tumbang sebagai petunjuk tentang kekuatan persatuan."Angkatan gelap penindasan sedang bergerak semula. Saya di sini hari ini untuk memberitahu anda di mana NATO berdiri dan apa yang kita harus lakukan untuk menghentikan perang sebelum ia bermula. Dan untuk melakukan itu, kita perlu jelas tentang ancaman. Kita adalah sasaran seterusnya Rusia. Dan kita sudah berada dalam bahaya," katanya.Ahli-ahli NATO berjanji pada Jun untuk meningkatkan perbelanjaan pertahanan kepada 5% daripada produk domestik kasar pada tahun 2035, mengikut panggilan Presiden untuk mengambil lebih banyak langkah untuk memperkuat keselamatan mereka.Rutte memberitahu peserta bahawa langkah itu bukan masa untuk berbangga diri kerana Rusia terus melakukan serangan drone dan rudal berskala besar."Saya bimbang terlalu ramai yang diam-diam complacent. terlalu ramai yang tidak merasakan kegerakbalas. Dan terlalu ramai yang berpendapat bahawa masa berada di pihak kita. Ia bukan," katanya.Pengarah NATO menyeru sekutu untuk meningkatkan perbelanjaan pertahanan dan pengeluaran, mengatakan tentera mereka mesti mempunyai sumber yang diperlukan untuk melindungi tanah air mereka, dan memberi amaran bahawa Moscow mungkin bersedia untuk menggunakan kekuatan militer terhadap NATO dalam masa lima tahun."Kita semua mesti menerima bahawa kita mesti bertindak untuk mempertahankan cara hidup kita, sekarang. Kerana tahun ini, Rusia telah menjadi lebih berani, berhina dan kejam terhadap NATO dan terhadap Ukraine," tambah Rutte. "Semasa Zaman Soal, Presiden Reagan memberi amaran tentang impuls serangan dari sebuah empayar jahat. Hari ini, Presiden Putin sedang dalam perniagaan membina empayar lagi."Poland menuduh Rusia bertanggungjawab atas di atas garis Warsaw-Lublin pada November.Perdana Menteri Donald Tusk berkata siasatan terhadap kejadian itu mendapati bahawa Perkhidmatan Rahsia Rusia "memerintahkan letupan kereta api Poland dan merekrut dua orang Ukraina untuk melakukannya."Letupan kereta api adalah kejadian keselamatan terbaru dalam satu rangkaian kejadian keselamatan di, selepas penyusupan ruang angkasa pada September yang melihat drone Rusia memasuki Poland dan tiga jet tempur MiG-31 merentasi ke Estonia sebelum dihalang oleh pesawat NATO.Artikel ini disediakan oleh pembekal kandungan pihak ketiga. SeaPRwire (https://www.seaprwire.com/) tidak memberi sebarang waranti atau perwakilan berkaitan dengannya. Sektor: Top Story, Berita Harian SeaPRwire menyampaikan edaran siaran akhbar secara masa nyata untuk syarikat dan institusi, mencapai lebih daripada 6,500 kedai media, 86,000 penyunting dan wartawan, dan 3.5 juta desktop profesional di seluruh 90 negara. SeaPRwire menyokong pengedaran siaran akhbar dalam bahasa Inggeris, Korea, Jepun, Arab, Cina Ringkas, Cina Tradisional, Vietnam, Thai, Indonesia, Melayu, Jerman, Rusia, Perancis, Sepanyol, Portugis dan bahasa-bahasa lain.
More
Israel melancarkan senjata laser Iron Beam sambil mencapai rekod jualan senjata $15 bilion kewangan

Israel melancarkan senjata laser Iron Beam sambil mencapai rekod jualan senjata $15 bilion

Disember 11, 2025
(SeaPRwire) - Israel bukan negara paling popular di dunia, kecuali apabila ia berkaitan dengan perkakasan ketenteraan. Negara sebesar New Jersey kini merupakan pengeksport senjata terbesar kelapan di dunia dengan jualan rekod $15 bilion pada tahun 2024.Di belakang Britain, tetapi di hadapan Turki dan Korea Selatan dalam jualan senjata asing, kerajaan-kerajaan berbondong-bondong ke Israel untuk membeli senjata yang telah diuji dalam pertempuran, terutamanya roket daripada sistem pertahanan peluru berpandu Iron Dome yang terkenal.Eropah menyumbang sebahagian besar daripada jualan — Jerman dan Finland ialah yang terbesar, tetapi India, Thailand dan Greece juga merupakan pembeli. Malah negara-negara majoriti Muslim — Maghribi, UAE dan Bahrain — membeli peluru berpandu, dron dan sistem siberkeselamatan daripada negara Yahudi ini.Jualan rekod ini berlaku semasa . Iron Beam ialah laser yang mampu memusnahkan peluru berpandu masuk, peluru mortar dan dron sehingga jarak 6 batu dengan kos serendah $2 setiap pencegahan. Sebagai perbandingan, peluru berpandu pencegah biasanya berharga antara $100,000 hingga $1 juta setiap satu."Dengan laser, satu-satunya kos ialah elektrik," kata Yuval Steinitz, pengerusi Rafael Defense Industries, pengeluar . "Ia seperti antara $1 dan $2, kurang daripada harga hot dog di New York."Tidak seperti pencegah peluru berpandu konvensional, walaupun ia cepat, memerlukan masa. Laser bergerak pada kelajuan cahaya."Kami telah menggunakannya terhadap UAV yang dilancarkan oleh Hizbullah di utara dan peluru berpandu daripada Iran. Ia berfungsi," kata profesor University of Tel Aviv Isaac Ben-David. "Kelebihan yang paling penting ialah, sebaik sahaja anda melihat sasaran, ia dicengahkan pada kelajuan cahaya. Ia mengambil sebahagian kecil daripada saat, dan laser sudah memusnahkannya."Selepas dekad ujian yang gagal oleh beberapa negara, Israel ialah negara pertama yang berjaya menggunakan senjata ini dalam perang. Salah seorang yang mengawasi pembangunan ialah profesor Isaac Ben-David, bekas ketua penyelidikan dan pembangunan di Kementerian Pertahanan Israel.Israel akan mengerahkan sistem Iron Beam pertama di utara, di mana roket Hizbullah yang dilancarkan dalam mengambil masa kurang daripada satu minit untuk melintasi sempadan Israel. Aplikasi akan diperluaskan untuk termasuk kapal dan pangkalan udara tertentu."Ini hanya permulaan era baru," kata Steinitz. "Pada masa hadapan, mungkin lima tahun, ia akan membolehkan kami menembak setiap objek musuh di udara sekitar Israel. Ia benar-benar perubahan permainan."Rafael membangunkan teknologi ini bersama Lockheed Martin berasaskan AS dan $1.2 bilion daripada . Steinitz berkata teknologi ini sudah dikongsi dengan program tenaga terarah Tentera Darat AS."Kami tidak boleh hidup tanpa Amerika Syarikat," katanya. "Tetapi kadang-kadang, dalam perkongsian, walaupun kerdil boleh menyumbang kepada raksasa."Artikel ini disediakan oleh pembekal kandungan pihak ketiga. SeaPRwire (https://www.seaprwire.com/) tidak memberi sebarang waranti atau perwakilan berkaitan dengannya. Sektor: Top Story, Berita Harian SeaPRwire menyampaikan edaran siaran akhbar secara masa nyata untuk syarikat dan institusi, mencapai lebih daripada 6,500 kedai media, 86,000 penyunting dan wartawan, dan 3.5 juta desktop profesional di seluruh 90 negara. SeaPRwire menyokong pengedaran siaran akhbar dalam bahasa Inggeris, Korea, Jepun, Arab, Cina Ringkas, Cina Tradisional, Vietnam, Thai, Indonesia, Melayu, Jerman, Rusia, Perancis, Sepanyol, Portugis dan bahasa-bahasa lain.
More
Pengjunam udara selamat selepas parasut simpanan terpasang secara tidak sengaja, menyebabkan dia tergantung dari pesawat terbang kewangan

Pengjunam udara selamat selepas parasut simpanan terpasang secara tidak sengaja, menyebabkan dia tergantung dari pesawat terbang

Disember 11, 2025
(SeaPRwire) - Seorang penerjun payung terlepas dan akhirnya selamat selepas payung simpanannya terbangun secara tidak sengaja dan tersangkut di ekor pesawat ketika pesawat itu sedang ...Biro Keselamatan Pengangkutan menjelaskan bahawa "pegangan payung simpanan tersangkut pada sayap pesawat, menyebabkan payung simpanan terbangun."Rakaman video kejadian menakutkan itu — yang berlaku pada bulan September — menunjukkan payung terbangun, dengan lelaki itu terbang ke arah ekor pesawat dan kemudian tergantung dari pesawat kerana payungnya tersangkut."Payung simpanan melilit penstabil mendatar kiri dan lif dan kempes apabila" kaki bawah penerjun payung itu "menyentuh penstabil," lanjutnya, menambah bahawa orang itu "kemudian tergantung di bawah sayap ekor."Orang itu dapat menggunakan pisau cangkuk untuk memotong tali payung."Payung simpanan kemudiannya koyak, melepaskan" orang itu "dari pesawat dengan sebahagian payung simpanan masih tinggal di ekor pesawat," catatan laporan ATSB.Setelah terlepas dari pesawat, penerjun payung itu dapat membuka payung utama dan mendarat — walaupun tidak tanpa menghadapi beberapa masalah.Laporan ATSB menyatakan bahawa "semasa pembukaan payung utama, sisa tali payung simpanan berpintal di sekeliling tali payung utama. Selain itu, semasa urutan pembukaan, tombol brek kanan payung utama terlepas.""Payung utama mengembang sepenuhnya dengan tali yang berpintal, dan selepas mula-mula berpusing ke kanan, mula berpusing ke kiri dengan cepat. Selepas beberapa putaran," penerjun payung itu "memegang dan menarik tali brek kanan di atas tali yang berpintal untuk menghentikan pusingan. Payung berhenti berpusing, dan" orang itu "dapat mengurai tali yang berpintal dan melepaskan tombol brek kiri. Lepas melepasi kira-kira 8,000 kaki, tali payung utama sepenuhnya terurai dari tali payung simpanan dan berfungsi normal untuk selebihnya penurunan."Pilot berjaya mendaratkan ..., menurut ATSB, yang mencatat bahawa penerjun payung itu "mendarat 9 saat kemudian dengan luka kecil dan lebam pada kaki bawah kiri mereka dan goresan dalam pada kaki bawah kanan mereka."Artikel ini disediakan oleh pembekal kandungan pihak ketiga. SeaPRwire (https://www.seaprwire.com/) tidak memberi sebarang waranti atau perwakilan berkaitan dengannya. Sektor: Top Story, Berita Harian SeaPRwire menyampaikan edaran siaran akhbar secara masa nyata untuk syarikat dan institusi, mencapai lebih daripada 6,500 kedai media, 86,000 penyunting dan wartawan, dan 3.5 juta desktop profesional di seluruh 90 negara. SeaPRwire menyokong pengedaran siaran akhbar dalam bahasa Inggeris, Korea, Jepun, Arab, Cina Ringkas, Cina Tradisional, Vietnam, Thai, Indonesia, Melayu, Jerman, Rusia, Perancis, Sepanyol, Portugis dan bahasa-bahasa lain.
More
Putin mengukuhkan sokongan kepada Maduro di tengah tekanan AS yang meningkat ke atas Venezuela kewangan

Putin mengukuhkan sokongan kepada Maduro di tengah tekanan AS yang meningkat ke atas Venezuela

Disember 11, 2025
(SeaPRwire) - Presiden Rusia bercakap melalui telefon dengan diktator Venezuela Nicolás Maduro pada hari Khamis dan meyakinkannya tentang sokongan Moscow ketika pemimpin Venezuela itu menghadapi tekanan luar yang semakin meningkat, menurut kenyataan dari Kremlin. Dalam panggilan tersebut, yang dilaporkan oleh Reuters, Putin menyatakan sokongan kepada kerajaan Maduro "dalam menghadapi tekanan luar yang semakin meningkat," ketika Amerika Syarikat di bawah Presiden terus mendesak agar Maduro dikeluarkan dari jawatan. Washington telah meningkatkan aktiviti ketenteraan di Lautan Caribbean sebagai sebahagian daripada kempen tekanannya. Kremlin berkata kedua-dua pemimpin membincangkan minat bersama mereka untuk memajukan perjanjian perkongsian strategik dan meneruskan projek bersama dalam sektor ekonomi dan tenaga. sebagai rakan utama di Amerika Latin, terutamanya ketika kedua-dua kerajaan menghadapi pengasingan dan sekatan antarabangsa. Panggilan itu berlaku sehari selepas Amerika Syarikat merampas sebuah kapal tangki minyak Venezuela yang besar, yang disanksikan oleh AS, di luar pantai negara tersebut, memperburukkan lagi hubungan yang sudah tegang antara Caracas dan Washington. Menurut, kerajaan Venezuela mengutuk rampasan itu sebagai pencabulan kedaulatannya dan menuduh Washington melakukan tindakan bermusuhan terhadap kepentingan ekonominya. Pentadbiran Trump telah mengintensifkan penguatkuasaan yang mensasarkan sektor minyak Venezuela, yang kekal sebagai tulang belakang kerajaan Maduro walaupun mengalami kemerosotan selama bertahun-tahun. Peguam Negara AS mengesahkan bahawa agensi persekutuan, termasuk FBI, Homeland Security Investigations dan U.S. Coast Guard, menjalankan operasi kapal tangki dan mengeluarkan rakaman video tak tersulit mengenai rampasan tersebut. Tindakan itu mengikuti waran persekutuan yang dikaitkan dengan pencabulan sekatan. Presiden, yang menggambarkan kapal tersebut sebagai kapal tangki terbesar yang pernah dirampas oleh Amerika Syarikat. Reuters melaporkan bahawa tindakan itu menyebabkan harga minyak meningkat dan menambah tekanan baru kepada hubungan AS–Venezuela. Rusia dan Venezuela telah mengekalkan hubungan rapat selama lebih dua dekad, perkongsian yang semakin mendalam semasa pentadbiran Hugo Chávez dan diteruskan di bawah Nicolás Maduro. Menurut Reuters, kerjasama antara kedua-dua negara telah memberi tumpuan kepada pertahanan, pengeluaran tenaga dan bantuan kewangan. Sejak beberapa tahun kebelakangan ini, Moscow telah membekalkan peralatan ketenteraan ke Caracas, menyokong syarikat minyak milik negara Venezuela melalui usaha sama, dan memperluas pinjaman serta talian kredit yang telah membantu mengekalkan fungsi sebahagian daripada sektor minyak negara tersebut. Venezuela telah mengambil pinjaman Rusia berjumlah berbilion-bilion dolar dan pengaturan pembiayaan yang dikaitkan dengan eksport minyak mentah Venezuela. Walaupun menghadapi sekatan antarabangsa yang mensasarkan kedua-dua kerajaan, Rusia secara konsisten menganggap Venezuela sebagai rakan strategik. Laporan U.S. Congressional Research Service menggambarkan hubungan tersebut sebagai kekal dan sebahagian besarnya tidak terjejas oleh perubahan politik jangka pendek atau tekanan luar. Moscow terus menawarkan sokongan diplomatik dan kerjasama ekonomi walaupun krisis domestik Venezuela semakin buruk dan kempen tekanan AS semakin meningkat. Digital's Ashley Carnahan, Associated Press dan Reuters menyumbang kepada laporan ini.Artikel ini disediakan oleh pembekal kandungan pihak ketiga. SeaPRwire (https://www.seaprwire.com/) tidak memberi sebarang waranti atau perwakilan berkaitan dengannya. Sektor: Top Story, Berita Harian SeaPRwire menyampaikan edaran siaran akhbar secara masa nyata untuk syarikat dan institusi, mencapai lebih daripada 6,500 kedai media, 86,000 penyunting dan wartawan, dan 3.5 juta desktop profesional di seluruh 90 negara. SeaPRwire menyokong pengedaran siaran akhbar dalam bahasa Inggeris, Korea, Jepun, Arab, Cina Ringkas, Cina Tradisional, Vietnam, Thai, Indonesia, Melayu, Jerman, Rusia, Perancis, Sepanyol, Portugis dan bahasa-bahasa lain.
More
HKTDC 4Q25 Export Confidence Index: 2026 Hong Kong Export Growth of 8-9%, Sustained AI product demand lays solid foundation for future expansion JCN Newswire

HKTDC 4Q25 Export Confidence Index: 2026 Hong Kong Export Growth of 8-9%, Sustained AI product demand lays solid foundation for future expansion

Disember 11, 2025
HONG KONG, December 11, 2025 - (ACN Newswire via SeaPRwire.com) – Hong Kong’s exports are expected to grow by between 8% and 9% in 2026, according to figures releaased today by the Hong Kong Trade Development Council (HKTDC). The forecast forms part of the HKTDC’s annual Export Outlook report and follows on from the city’s better-than-anticipated 2025 export performance.For 2026, this sustained growth is set to be driven by robust demand for AI-related electronics products. According to the findings of the recently-released HKTDC 4Q25 Export Confidence Index, the majority of exporters (53.2%) see rising demand for AI/new technology-related electronic consumer goods as the factor most likely to boost their 2026 business. This is seen as crucial given that the electronics sector, overall, accounts for more than 70% of Hong Kong’s total export value.Heightened uncertainty giving way to greater clarityThese upbeat figures are remarkable given the high year-on-year comparison base from 2025. This is because many exporters sought to frontload orders in a bid to complete shipments before the imposition of the much-anticipated US tariffs.Detailing the upshot of the tariff-related trade upheavals in particular, Irina Fan, Director of HKTDC Research, said: “While 2025 proved to be a year of heightened uncertainty, 2026 should be a year of greater clarity on global trade. With the Chinese Mainland and the US having come to a trade agreement in November, – some four months after many other nations had struck their own deals with the Trump administration – US tariffs are no longer among Hong Kong exporters' three biggest 2026 concerns.”Fan did, however, acknowledge that uncertainties remain ahead. She said that as US imports from different countries are subject to different levels of tariffs, business leaders around the world will be looking to re-organise their activities to optimise any cost advantages.Outlining what this will mean within the Asia-Pacific region, Fan said: “Chinese Mainland exports to the US will be subject to 20% reciprocal tariff rate until November 2026 [1]. This comparatively low additional tariff puts China-based suppliers, many with more mature and highly productive supply chains, on par with their Southeast Asia counterparts, while giving them a significant advantage over any country subject to a higher tariff rate.”Multi-sector expectation of continued export expansionUnderpinning Hong Kong’s anticipated 2026 export expansion are the findings of the HKTDC Export Confidence Index 4Q25, which was also released today. The two key measures of this long-established quarterly metric –the Current Performance Index (51.4) and the Expectation Index (51.9) – have both stayed above the 50-point watershed level, a clear indication that future export growth is expected.Commenting on the findings of the 4Q25 survey, Kenneth Lee, Head of the HKTDC Research’s Special Project and Business Advisory Section, said: “When it comes to expansion plans over the next two-year period, Asia remains very much the focus. For 42.0% of respondents, the Chinese Mainland was the highest priority market, followed by the rest of Asia (30.3%) and the ASEAN bloc (18.9%). By industry, exporters in almost every sector saw scaling up their activities on the Chinese Mainland as their priority.”Beyond the headline findings of the survey, a more detailed analysis highlights good news for Hong Kong exporters in terms of both individual market prospects and the likely future success of most of the city’s key industry sectors.Positive sentiments for major markets and key industry sectorsIn specific terms, turning to the Market Expectation Sub-Index, the Chinese Mainland (57.2) and the ASEAN bloc (57.0) are still considered to have significant growth potential. Predictably, this was less the case for the US (down 1.4 to 38.0), with the uncertainties in its trade environment continuing to unsettle Hong Kong exporters.Turning to individual industries, a number of sectors have expansionary expectations for the year ahead (i.e. had a relevant index reading of 50 or more). Topping the list is Jewellery (54.8), followed by Electronics (52.4), Timepieces (51.6) and Equipment/Materials (51.1).Despite such overall positive sentiments, the survey also points out the possibility that a number of challenges may lie ahead. Most notably, it cited rising labour and production costs (53.9%), growing logistics challenges (38.8%) and declining overseas orders on account of the general economic slowdown (38.2%) as potential future concerns.[1] On top of Trump 1.0 tariffs of ~20% on averageReferencesHong Kong 2026 Export Outlook: Sustained AI Product Demand Set to Drive 8-9% Growth Over Coming Year:https://research.hktdc.com/en/article/MjE4ODc2Mzk2NwHKTDC Export Confidence Index 4Q25: End-of-Year Figures Indicate Positive Expansion Prospects:https://research.hktdc.com/en/article/MjE4ODYyNTQwNwHKTDC Research website: https://research.hktdc.com/en/ Photo download: https://bit.ly/4oJPrPRHKTDC Director of Research Irina Fan (right) and HKTDC Section Head, Special Project & Business Advisory, Kenneth Lee (left) announced the HKTDC Export Confidence Index for 2025’s fourth quarter at a press conference todayHKTDC Director of Research Irina FanHKTDC Section Head, Special Project & Business Advisory Kenneth LeeMedia enquiriesPlease contact the HKTDC’s Communication and Public Affairs Department:Navin LawTel: (852) 2584 4525Email: navin.cm.law@hktdc.orgAgnes WatTel: (852) 2584 4554Email: agnes.ky.wat@hktdc.orgAbout HKTDCThe Hong Kong Trade Development Council (HKTDC) is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With over 50 offices globally, including 13 in Mainland China, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus. Copyright 2025 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com
More
2026 Hong Kong Export Growth of 8-9%, Sustained AI product demand lays solid foundation for future expansion ACN Newswire

2026 Hong Kong Export Growth of 8-9%, Sustained AI product demand lays solid foundation for future expansion

Disember 11, 2025
HONG KONG, December 11, 2025 - (ACN Newswire via SeaPRwire.com) – Hong Kong’s exports are expected to grow by between 8% and 9% in 2026, according to figures releaased today by the Hong Kong Trade Development Council (HKTDC). The forecast forms part of the HKTDC’s annual Export Outlook report and follows on from the city’s better-than-anticipated 2025 export performance.For 2026, this sustained growth is set to be driven by robust demand for AI-related electronics products. According to the findings of the recently-released HKTDC 4Q25 Export Confidence Index, the majority of exporters (53.2%) see rising demand for AI/new technology-related electronic consumer goods as the factor most likely to boost their 2026 business. This is seen as crucial given that the electronics sector, overall, accounts for more than 70% of Hong Kong’s total export value.Heightened uncertainty giving way to greater clarityThese upbeat figures are remarkable given the high year-on-year comparison base from 2025. This is because many exporters sought to frontload orders in a bid to complete shipments before the imposition of the much-anticipated US tariffs.Detailing the upshot of the tariff-related trade upheavals in particular, Irina Fan, Director of HKTDC Research, said: “While 2025 proved to be a year of heightened uncertainty, 2026 should be a year of greater clarity on global trade. With the Chinese Mainland and the US having come to a trade agreement in November, – some four months after many other nations had struck their own deals with the Trump administration – US tariffs are no longer among Hong Kong exporters' three biggest 2026 concerns.”Fan did, however, acknowledge that uncertainties remain ahead. She said that as US imports from different countries are subject to different levels of tariffs, business leaders around the world will be looking to re-organise their activities to optimise any cost advantages.Outlining what this will mean within the Asia-Pacific region, Fan said: “Chinese Mainland exports to the US will be subject to 20% reciprocal tariff rate until November 2026 [1]. This comparatively low additional tariff puts China-based suppliers, many with more mature and highly productive supply chains, on par with their Southeast Asia counterparts, while giving them a significant advantage over any country subject to a higher tariff rate.”Multi-sector expectation of continued export expansionUnderpinning Hong Kong’s anticipated 2026 export expansion are the findings of the HKTDC Export Confidence Index 4Q25, which was also released today. The two key measures of this long-established quarterly metric –the Current Performance Index (51.4) and the Expectation Index (51.9) – have both stayed above the 50-point watershed level, a clear indication that future export growth is expected.Commenting on the findings of the 4Q25 survey, Kenneth Lee, Head of the HKTDC Research’s Special Project and Business Advisory Section, said: “When it comes to expansion plans over the next two-year period, Asia remains very much the focus. For 42.0% of respondents, the Chinese Mainland was the highest priority market, followed by the rest of Asia (30.3%) and the ASEAN bloc (18.9%). By industry, exporters in almost every sector saw scaling up their activities on the Chinese Mainland as their priority.”Beyond the headline findings of the survey, a more detailed analysis highlights good news for Hong Kong exporters in terms of both individual market prospects and the likely future success of most of the city’s key industry sectors.Positive sentiments for major markets and key industry sectorsIn specific terms, turning to the Market Expectation Sub-Index, the Chinese Mainland (57.2) and the ASEAN bloc (57.0) are still considered to have significant growth potential. Predictably, this was less the case for the US (down 1.4 to 38.0), with the uncertainties in its trade environment continuing to unsettle Hong Kong exporters.Turning to individual industries, a number of sectors have expansionary expectations for the year ahead (i.e. had a relevant index reading of 50 or more). Topping the list is Jewellery (54.8), followed by Electronics (52.4), Timepieces (51.6) and Equipment/Materials (51.1).Despite such overall positive sentiments, the survey also points out the possibility that a number of challenges may lie ahead. Most notably, it cited rising labour and production costs (53.9%), growing logistics challenges (38.8%) and declining overseas orders on account of the general economic slowdown (38.2%) as potential future concerns.[1] On top of Trump 1.0 tariffs of ~20% on averageReferencesHong Kong 2026 Export Outlook: Sustained AI Product Demand Set to Drive 8-9% Growth Over Coming Year:https://research.hktdc.com/en/article/MjE4ODc2Mzk2NwHKTDC Export Confidence Index 4Q25: End-of-Year Figures Indicate Positive Expansion Prospects:https://research.hktdc.com/en/article/MjE4ODYyNTQwNwHKTDC Research website: https://research.hktdc.com/en/ Photo download: https://bit.ly/4oJPrPRHKTDC Director of Research Irina Fan (right) and HKTDC Section Head, Special Project & Business Advisory, Kenneth Lee (left) announced the HKTDC Export Confidence Index for 2025’s fourth quarter at a press conference todayHKTDC Director of Research Irina FanHKTDC Section Head, Special Project & Business Advisory Kenneth LeeMedia enquiriesPlease contact the HKTDC’s Communication and Public Affairs Department:Navin LawTel: (852) 2584 4525Email: navin.cm.law@hktdc.orgAgnes WatTel: (852) 2584 4554Email: agnes.ky.wat@hktdc.orgAbout HKTDCThe Hong Kong Trade Development Council (HKTDC) is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With over 50 offices globally, including 13 in Mainland China, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus. Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More

Venezuela menuduh AS melakukan ‘pembajakan’ selepas merampas tanker minyak besar

Disember 11, 2025
(SeaPRwire) - Venezuela pada Rabu mengutuk penyerahan oleh AS terhadap sebuah di luar pantainya, menyebutnya sebagai "tindakan perompakan antarabangsa"."Republik Bolivarian Venezuela dengan tegas menentang dan menolak apa yang merupakan pencurian terang-terangan dan tindakan perompakan antarabangsa, yang diumumkan secara terbuka oleh presiden Amerika Syarikat, yang mengaku menyerang kapal minyak di Laut Karibia," kata kerajaan dalam suatu Penyataan itu, yang diterbitkan oleh Correo del Orinoco, sebuah media berita milik kerajaan yang selalu menyampaikan pengumuman rasmi kerajaan Venezuela, membayangkan penyerahan itu sebagai sebahagian daripada kempen lebih luas terhadap kedaulatan dan sumber alam negara itu.Peguam Negara berkata operasi bersama dengan Federal Bureau of Investigation, Homeland Security Investigations dan United States Coast Guard, dengan sokongan daripada Jabatan Perang, melaksanakan waran penyerahan untuk sebuah kapal minyak mentah yang didakwa digunakan untuk mengangkut minyak yang disekat dari Venezuela dan Iran."Selama beberapa tahun, kapal minyak itu telah disekat oleh Amerika Syarikat kerana penglibatannya dalam rangkaian penghantaran minyak haram yang menyokong organisasi pengganas asing," katanya di X. "Penyerahan ini, yang diselesaikan di luar pantai Venezuela, dijalankan dengan selamat dan aman—and siasatan kami bersama untuk menghalang penghantaran minyak yang disekat berterusan."Bondi mengeluarkan mengenai operasi itu yang menunjukkan helikopter menghampiri kapal minyak besar dan kakitangan taktikal menurun dengan tali ke dek.Presiden membuat pengumuman penyerahan itu pada Rabu semasa bercakap di acara meja bulat di White House dengan pemimpin perniagaan."Seperti yang anda mungkin tahu, kami baru sahaja menyekat sebuah kapal di . Kapal besar, sangat besar, sebenarnya yang terbesar pernah disekat," kata Trump kepada wartawan. "Dan, perkara lain sedang berlaku. Jadi anda akan melihatnya kemudian, dan anda akan bercakap tentangnya kemudian dengan sesetengah orang lain.""Ia disekat kerana sebab yang sangat baik," tambahnya kemudian.Diberi soalan oleh wartawan apa yang akan berlaku kepada minyak di atas kapal itu, Trump menjawab: "Nah, kami simpan ia, saya rasa."Beberapa masa kemudian, dia berkata, "Saya anggap kita akan menyimpan minyak itu."Artikel ini disediakan oleh pembekal kandungan pihak ketiga. SeaPRwire (https://www.seaprwire.com/) tidak memberi sebarang waranti atau perwakilan berkaitan dengannya. Sektor: Top Story, Berita Harian SeaPRwire menyampaikan edaran siaran akhbar secara masa nyata untuk syarikat dan institusi, mencapai lebih daripada 6,500 kedai media, 86,000 penyunting dan wartawan, dan 3.5 juta desktop profesional di seluruh 90 negara. SeaPRwire menyokong pengedaran siaran akhbar dalam bahasa Inggeris, Korea, Jepun, Arab, Cina Ringkas, Cina Tradisional, Vietnam, Thai, Indonesia, Melayu, Jerman, Rusia, Perancis, Sepanyol, Portugis dan bahasa-bahasa lain.
More

CMS (867/8A8): NDA of Innovative Drug Y-3 for Injection for Acute Ischemic Stroke Accepted in China

Disember 11, 2025
SHENZHEN, Dec 11, 2025 – (ACN Newswire) – China Medical System Holdings Limited (the “Group” or “CMS”) is pleased to announce that on 11 December 2025, the New Drug Application (NDA) of Class 1 Innovative Drug Y-3 for Injection (proposed English generic name: Loberamisal for Injection) (“Y-3 for Injection” or the “Product”) has been accepted by National Medical Products Administration of the People’s Republic of China (NMPA). The Product is a brain cytoprotectant indicated for the treatment of acute ischemic stroke. With well-defined targets and clear mechanism of action, Y-3 for Injection is able to exert multiple therapeutic effects. As the world’s first brain cytoprotectant developed based on the important targets PSD95-nNOS and MPO, in the pathological processes of stroke, Y-3 for Injection acts on multiple key pathological processes of the ischemic cascade in ischemic stroke. Through multi-target, highly selective synergy, it is more conducive to exerting brain cytoprotective effects. The Product has an excellent therapeutic effect on ischemic stroke and the potential to prevent post-stroke depression and anxiety symptoms. Y-3 for Injection demonstrates excellent clinical data with excellent efficacy and a favorable safety profile. The results of Phase II clinical trial of the Product in China indicated that among patients with ischemic stroke within 48 hours of onset, patients in the Y-3 group (40mg, qd) demonstrated a significantly higher proportion of patients achieving an excellent functional outcome (mRS of 0-1) at 90 days than those in the placebo group, with a rate difference of 16%. The Phase III clinical trial of the Product in China was conducted by Beijing Tiantan Hospital, Capital Medical University as the leading site. It has enrolled nearly 1,000 patients with acute ischemic stroke within 48 hours of onset across approximately 40 research centers nationwide, aiming to evaluate the efficacy and safety of Y-3 for Injection in treating patients with acute ischemic stroke within 48 hours of onset. The Phase III clinical study met the primary efficacy endpoint, with patients achieving significant clinical benefits and an overall favorable safety profile. The key study results are planned to be presented at international academic conferences, and the full study will be published in international academic journals. The Central Nervous System (CNS) is one of the core advantageous fields of CMS, where a deeply integrated layout has been progressively established. The product portfolio has solidified the market foundation, including the marketed innovative drug VALTOCO (Diazepam Nasal Spray), the original brand drug Deanxit (Flupentixol and Melitracen Tablets), and the improved new drug ZUNVEYL (Benzgalantamine Gluconate Enteric-coated Tablets), which is currently under NDA review. The addition of Y-3 for Injection will further strengthen the product portfolio, generating highly efficient synergies in terms of expert networks and market resources. It is expected that if approved for marketing, Y-3 for Injection will bring a new generation of brain cytoprotectant with excellent efficacy and more comprehensive therapeutic effects to Chinese patients with ischemic stroke. Leveraging the successful commercialization experience and compliant and efficient operation system, the Group will accelerate the accessibility of innovative therapies to benefit more patients. More Information about Y-3 for Injection The pathological processes of acute ischemic stroke are highly complex and interconnected. There is an urgent clinical need for multi-target, multi-mechanism coordinated interventions to achieve more effective regulation of the complex ischemic cascade, thereby improving treatment outcomes and enhancing patients’ quality of life. Y-3 for Injection is able to uncouple PSD95-nNOS, inhibit MPO activity, and enhance the activity of α2-GABAA receptor (a subtype of GABAA receptor with antidepressant and anxiolytic effects). With this multi-target, highly selective synergistic mechanism, it is expected to achieve a technological breakthrough in the simultaneous intervention of “stroke treatment and prevention of post-stroke depression and anxiety”, making Y-3 for Injection a promising novel brain cytoprotectant with excellent efficacy and more comprehensive therapeutic effects. The results of Phase II clinical trial of Y-3 for Injection for the treatment of acute ischemic stroke were presented as an oral poster at the 10th European Stroke Organisation Conference in 2024 (ESOC 2024). It indicated that among patients with ischemic stroke within 48 hours of onset, patients in the Y-3 group (20mg, 40mg, 60mg, qd) demonstrated a significantly higher proportion of patients achieving an excellent functional outcome (mRS of 0-1) at 90 days than those in the placebo group (20mg: 67.8% vs 60.7%, 40mg: 76.7% vs 60.7%, 60mg: 70.0% vs 60.7%). Moreover, the Product showed comparable safety to placebo in acute ischemic stroke patients, exhibiting good tolerability. On 24 August 2023, the Group through its wholly-owned subsidiary entered into a Collaboration Agreement (the “Agreement”) with Neurodawn Pharmaceutical Co., Ltd. (“NeuroDawn”), a clinical needs-oriented pharmaceutical company driven by innovation and R&D. In accordance with the Agreement, the Group obtains an exclusive promotion right in mainland China, the Hong Kong Special Administrative Region, and the Macau Special Administrative Region. The term of the Agreement is permanent. About Stroke According to the Guideline for Prevention and Treatment of Cerebrovascular Disease (2024 Edition) issued by the National Health Commission, approximately 3.94 million new stroke cases occur in China each year, accounting for one-third of the global new cases[1]. Among these, ischemic stroke accounts for about 72%, with over 2.8 million new cases annually; the number of existing stroke patients in China has exceeded 28 million[1]. Data from China’s cause-of-death monitoring in 2021 shows that stroke-related deaths accounted for 23% of the national total deaths[1]. Over the past three decades, the disease burden of stroke-related disabilities in China has continued to increase[1]. Coupled with factors such as the accelerating aging of the population, the pressure of stroke prevention and control will further intensify in the future, posing enormous challenges to patients’ families and society[1]. In addition, post-stroke depression and anxiety are common complications of stroke, with incidence rates of approximately 30% and 25% respectively[2]. They can hinder the recovery of patients’ neurological functions, even increase the risk of death, and severely affect patients’ prognosis. Y-3 for Injection holds significant potential value for the long-term neurological function improvement and overall prognosis of a vast number of stroke patients, indicating broad market prospects. About CMS CMS is a platform company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability, dedicated to providing competitive products and services to meet unmet medical needs. CMS focuses on the global first-in-class (FIC) and best-in-class (BIC) innovative products, and efficiently promotes the clinical research, development and commercialization of innovative products, enabling the continuous transformation of scientific research into clinical practices to benefit patients. CMS deeply engages in several specialty therapeutic fields, and has developed proven commercialization capabilities, extensive networks and expert resources, resulting in leading academic and market positions for its major marketed products. CMS continues to promote the in-depth development in its advantageous specialty fields, strengthening the competitiveness of the cardio-cerebrovascular/ gastroenterology/ ophthalmology/ skin health businesses, bringing economies of scale in specialty fields. Among them, the skin health business (Dermavon) has become a leading enterprise in its field, and is proposed to be listed independently on the SEHK. Meanwhile, CMS continuously promotes the operation and development of its integrated R&D, manufacturing and commercialization chain in Southeast Asia and the Middle East, capturing growth opportunities in emerging markets to support the high-quality and sustainable development of the Group. Reference 1. National Health Commission of the People’s Republic of China. Guideline for Prevention and Treatment of Cerebrovascular Disease (2024 Edition) [J]. Chinese Journal of Magnetic Resonance Imaging, 2025, 16(1): 1-8. DOI: 10.12015/issn.1674-8034.2025.01.001. 2. Chen Xinyu, Lyu Xiaohan, Li Ruina, et al. Post-Stroke Anxiety [J]. International Journal of Cerebrovascular Disease, 2022, 30(2): 129-133. DOI: 10.3760/cma.j.issn.1673-4165.2022.02.010. CMS Disclaimer and Forward-Looking Statements This press release is not intended to promote any products to you and is not for advertising purposes. This press release does not recommend any drugs, medical devices and/or indications. If you want to know more about the diagnosis and treatment of specific diseases, please follow the opinions or guidance of your doctor or other medical and health professionals. Any treatment-related decisions made by healthcare professionals should be based on the patient’s specific circumstances and in accordance with the drug package insert. This press release which has been prepared by CMS does not constitute any offer or invitation to purchase or subscribe for any securities, and shall not form the basis for or be relied on in connection with any contract or binding commitment whatsoever. This press release has been prepared by CMS based on information and data which it considers reliable, but CMS makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this press release. Certain matters discussed in this press release may contain statements regarding the Group’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. Any forward-looking statements and projections made by third parties included in this press release are not adopted by the Group and the Company is not responsible for such third-party statements and projections. Media ContactBrand: China Medical System Holdings Ltd.Contact: CMS Investor RelationsEmail: ir@cms.net.cnWebsite: https://web.cms.net.cn/en/home/
More
CMS (867/8A8): NDA of Innovative Drug Y-3 for Injection for Acute Ischemic Stroke Accepted in China ACN Newswire

CMS (867/8A8): NDA of Innovative Drug Y-3 for Injection for Acute Ischemic Stroke Accepted in China

Disember 11, 2025
SHENZHEN, Dec 11, 2025 - (ACN Newswire via SeaPRwire.com) - China Medical System Holdings Limited (the “Group” or “CMS”) is pleased to announce that on 11 December 2025, the New Drug Application (NDA) of Class 1 Innovative Drug Y-3 for Injection (proposed English generic name: Loberamisal for Injection) (“Y-3 for Injection” or the “Product”) has been accepted by National Medical Products Administration of the People’s Republic of China (NMPA). The Product is a brain cytoprotectant indicated for the treatment of acute ischemic stroke.With well-defined targets and clear mechanism of action, Y-3 for Injection is able to exert multiple therapeutic effects. As the world’s first brain cytoprotectant developed based on the important targets PSD95-nNOS and MPO, in the pathological processes of stroke, Y-3 for Injection acts on multiple key pathological processes of the ischemic cascade in ischemic stroke. Through multi-target, highly selective synergy, it is more conducive to exerting brain cytoprotective effects. The Product has an excellent therapeutic effect on ischemic stroke and the potential to prevent post-stroke depression and anxiety symptoms.Y-3 for Injection demonstrates excellent clinical data with excellent efficacy and a favorable safety profile. The results of Phase II clinical trial of the Product in China indicated that among patients with ischemic stroke within 48 hours of onset, patients in the Y-3 group (40mg, qd) demonstrated a significantly higher proportion of patients achieving an excellent functional outcome (mRS of 0-1) at 90 days than those in the placebo group, with a rate difference of 16%. The Phase III clinical trial of the Product in China was conducted by Beijing Tiantan Hospital, Capital Medical University as the leading site. It has enrolled nearly 1,000 patients with acute ischemic stroke within 48 hours of onset across approximately 40 research centers nationwide, aiming to evaluate the efficacy and safety of Y-3 for Injection in treating patients with acute ischemic stroke within 48 hours of onset. The Phase III clinical study met the primary efficacy endpoint, with patients achieving significant clinical benefits and an overall favorable safety profile. The key study results are planned to be presented at international academic conferences, and the full study will be published in international academic journals.The Central Nervous System (CNS) is one of the core advantageous fields of CMS, where a deeply integrated layout has been progressively established. The product portfolio has solidified the market foundation, including the marketed innovative drug VALTOCO (Diazepam Nasal Spray), the original brand drug Deanxit (Flupentixol and Melitracen Tablets), and the improved new drug ZUNVEYL (Benzgalantamine Gluconate Enteric-coated Tablets), which is currently under NDA review. The addition of Y-3 for Injection will further strengthen the product portfolio, generating highly efficient synergies in terms of expert networks and market resources. It is expected that if approved for marketing, Y-3 for Injection will bring a new generation of brain cytoprotectant with excellent efficacy and more comprehensive therapeutic effects to Chinese patients with ischemic stroke. Leveraging the successful commercialization experience and compliant and efficient operation system, the Group will accelerate the accessibility of innovative therapies to benefit more patients.More Information about Y-3 for InjectionThe pathological processes of acute ischemic stroke are highly complex and interconnected. There is an urgent clinical need for multi-target, multi-mechanism coordinated interventions to achieve more effective regulation of the complex ischemic cascade, thereby improving treatment outcomes and enhancing patients’ quality of life. Y-3 for Injection is able to uncouple PSD95-nNOS, inhibit MPO activity, and enhance the activity of α2-GABAA receptor (a subtype of GABAA receptor with antidepressant and anxiolytic effects). With this multi-target, highly selective synergistic mechanism, it is expected to achieve a technological breakthrough in the simultaneous intervention of “stroke treatment and prevention of post-stroke depression and anxiety”, making Y-3 for Injection a promising novel brain cytoprotectant with excellent efficacy and more comprehensive therapeutic effects.The results of Phase II clinical trial of Y-3 for Injection for the treatment of acute ischemic stroke were presented as an oral poster at the 10th European Stroke Organisation Conference in 2024 (ESOC 2024). It indicated that among patients with ischemic stroke within 48 hours of onset, patients in the Y-3 group (20mg, 40mg, 60mg, qd) demonstrated a significantly higher proportion of patients achieving an excellent functional outcome (mRS of 0-1) at 90 days than those in the placebo group (20mg: 67.8% vs 60.7%, 40mg: 76.7% vs 60.7%, 60mg: 70.0% vs 60.7%). Moreover, the Product showed comparable safety to placebo in acute ischemic stroke patients, exhibiting good tolerability.On 24 August 2023, the Group through its wholly-owned subsidiary entered into a Collaboration Agreement (the “Agreement”) with Neurodawn Pharmaceutical Co., Ltd. (“NeuroDawn”), a clinical needs-oriented pharmaceutical company driven by innovation and R&D. In accordance with the Agreement, the Group obtains an exclusive promotion right in mainland China, the Hong Kong Special Administrative Region, and the Macau Special Administrative Region. The term of the Agreement is permanent.About StrokeAccording to the Guideline for Prevention and Treatment of Cerebrovascular Disease (2024 Edition) issued by the National Health Commission, approximately 3.94 million new stroke cases occur in China each year, accounting for one-third of the global new cases[1]. Among these, ischemic stroke accounts for about 72%, with over 2.8 million new cases annually; the number of existing stroke patients in China has exceeded 28 million[1]. Data from China’s cause-of-death monitoring in 2021 shows that stroke-related deaths accounted for 23% of the national total deaths[1]. Over the past three decades, the disease burden of stroke-related disabilities in China has continued to increase[1]. Coupled with factors such as the accelerating aging of the population, the pressure of stroke prevention and control will further intensify in the future, posing enormous challenges to patients’ families and society[1]. In addition, post-stroke depression and anxiety are common complications of stroke, with incidence rates of approximately 30% and 25% respectively[2]. They can hinder the recovery of patients’ neurological functions, even increase the risk of death, and severely affect patients’ prognosis. Y-3 for Injection holds significant potential value for the long-term neurological function improvement and overall prognosis of a vast number of stroke patients, indicating broad market prospects.About CMSCMS is a platform company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability, dedicated to providing competitive products and services to meet unmet medical needs.CMS focuses on the global first-in-class (FIC) and best-in-class (BIC) innovative products, and efficiently promotes the clinical research, development and commercialization of innovative products, enabling the continuous transformation of scientific research into clinical practices to benefit patients.CMS deeply engages in several specialty therapeutic fields, and has developed proven commercialization capabilities, extensive networks and expert resources, resulting in leading academic and market positions for its major marketed products. CMS continues to promote the in-depth development in its advantageous specialty fields, strengthening the competitiveness of the cardio-cerebrovascular/ gastroenterology/ ophthalmology/ skin health businesses, bringing economies of scale in specialty fields. Among them, the skin health business (Dermavon) has become a leading enterprise in its field, and is proposed to be listed independently on the SEHK. Meanwhile, CMS continuously promotes the operation and development of its integrated R&D, manufacturing and commercialization chain in Southeast Asia and the Middle East, capturing growth opportunities in emerging markets to support the high-quality and sustainable development of the Group.Reference1. National Health Commission of the People’s Republic of China. Guideline for Prevention and Treatment of Cerebrovascular Disease (2024 Edition) [J]. Chinese Journal of Magnetic Resonance Imaging, 2025, 16(1): 1-8. DOI: 10.12015/issn.1674-8034.2025.01.001.2. Chen Xinyu, Lyu Xiaohan, Li Ruina, et al. Post-Stroke Anxiety [J]. International Journal of Cerebrovascular Disease, 2022, 30(2): 129-133. DOI: 10.3760/cma.j.issn.1673-4165.2022.02.010.CMS Disclaimer and Forward-Looking StatementsThis press release is not intended to promote any products to you and is not for advertising purposes. This press release does not recommend any drugs, medical devices and/or indications. If you want to know more about the diagnosis and treatment of specific diseases, please follow the opinions or guidance of your doctor or other medical and health professionals. Any treatment-related decisions made by healthcare professionals should be based on the patient’s specific circumstances and in accordance with the drug package insert.This press release which has been prepared by CMS does not constitute any offer or invitation to purchase or subscribe for any securities, and shall not form the basis for or be relied on in connection with any contract or binding commitment whatsoever. This press release has been prepared by CMS based on information and data which it considers reliable, but CMS makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this press release. Certain matters discussed in this press release may contain statements regarding the Group’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. Any forward-looking statements and projections made by third parties included in this press release are not adopted by the Group and the Company is not responsible for such third-party statements and projections.Media ContactBrand: China Medical System Holdings Ltd.Contact: CMS Investor RelationsEmail: ir@cms.net.cnWebsite: https://web.cms.net.cn/en/home/ Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
Eisai Rated “A”, the Highest Rating by CDP in Both Climate Change and Water Security Categories for the Second Consecutive Year JCN Newswire

Eisai Rated “A”, the Highest Rating by CDP in Both Climate Change and Water Security Categories for the Second Consecutive Year

Disember 11, 2025
TOKYO, Dec 11, 2025 - (JCN Newswire via SeaPRwire.com) - Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) has announced that it has been selected for the highest-rated “A” List in the fields of Climate Change and Water Security for 2025 by the global environmental non-profit organization CDP.(1) This marks the second consecutive year the company has been named in both categories of the CDP’s A List.Based on Eisai’s Future Creation Strategy(2) (Sustainability Strategy), the company is committed to addressing material issues and social challenges over the mid- to long- term, with the aim of contributing to sustainable corporate growth and the sustainable development of society. In the field of environmental conservation, Eisai has identified “Business activities with consideration for the global environment” as one of our material issues. Based on the Eisai Network Companies Environmental Policy, Eisai is promoting responses to climate change and sustainable water use as environmental activities across the group.As part of its climate change response, Eisai is working towards the realization of a decarbonized society, including obtaining approval for the SBT 1.5'C target from the Science Based Targets (SBT) Initiative in FY2023, and participating in the Japan Climate Initiative (JCI) Race to Zero Circle, which calls for achieving net zero by 2050. Through these efforts, Eisai is contributing to the reduction of greenhouse gas emissions.(3) Regarding sustainable water use, Eisai has set its mid-term target to reduce water withdrawal across the company by 7%(4) by FY2030 compared to FY2023, promoting efficient use of water resources, including recycling of laboratory wastewater and rainwater. Please refer to Eisai’s website for more detailed information about its environmental activities.To realize the human health care (hhc) concept, conservation of the global environment is essential. Eisai is committed to empowering people to “realize their fullest lives” through initiatives addressing climate change and the promotion sustainable water use.(1) A non-profit organization headquartered in the UK. The organization operates the world’s only independent environmental information disclosure system(2) Please refer to Eisai Value Creation Report (https://www.eisai.com/ir/library/annual/pdf/pdf2025vcr.pdf)(3) Please refer to the following news release for details. EISAI TO BOOST INITIATIVES ON GREENHOUSE GAS REDUCTION, AIMING TO ACHIEVE NET ZERO BY 2050 (https:/www.eisai.com/news/2024/news202412.html)(4) Per unit of salesMedia Inquiries:Public Relations Department,Eisai Co., Ltd.+81-(0)3-3817-5120 Copyright 2025 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com
More
Focus Graphite Achieves 99.9996 wt.% Ultra-High Purity and 2.03 ppm EBC in Follow-On Testing ACN Newswire

Focus Graphite Achieves 99.9996 wt.% Ultra-High Purity and 2.03 ppm EBC in Follow-On Testing

Disember 11, 2025
5N+ Purity and On-Spec EBC Confirm Lac Knife's Potential as a North American Source of Ultra-High-Performance Graphite ApplicationsOttawa, Ontario--(ACN Newswire via SeaPRwire.com - December 11, 2025) - Focus Graphite Inc. (TSXV: FMS) (OTCQB: FCSMF) (FSE: FKC0) ("Focus" or the "Company") a Canadian developer of high-grade flake graphite deposits and innovator of next-generation battery technology, is pleased to announce that follow-on purification and elemental analysis of material from its Lac Knife deposit (concentrate Lot ID: GN25073005) achieved 99.9996 wt.% ("5N+") and an Equivalent Boron Concentration ("EBC") of 2.03 ppm, confirming the material is within nuclear-grade specification and meets the technical thresholds required for several high-value advanced materials markets.The test work, conducted using electrothermal purification with no halogen gases (e.g. chlorine) or acids, produced this ultra-pure result in two (2) hours, further validating a chemical-free, environmentally advantageous pathway compared to conventional purification methods. These results directly support Focus's ongoing engineering and scale-up programs funded under Natural Resources Canada's ("NRCan") Global Partnerships Initiative ("GPI"), under which the Company was awarded a non-repayable contribution of up to $14.1 million to accelerate North American capacity for clean, advanced material processing.Subsequent elemental analysis calculated in accordance with ASTM C1233-15: Standard Practice for Determining Equivalent Boron Contents of Nuclear Materials yielded an Equivalent Boron Concentration ("EBC") of 2.03 ppm (Table 1), which falls below the critical 3 ppm threshold often cited for nuclear-grade graphite applications. The calculated EBC value is the most critical test of purity for nuclear industry use.These results suggest that Lac Knife graphite has the potential to serve markets requiring ultra-high-purity large and jumbo flake natural graphite. Achieving both 5N+ purity and a high proportion of large-flake concentrate is uncommon in the natural graphite industry and may provide Focus with opportunities in markets historically reliant on synthetic graphite or otherwise inaccessible to peers. These findings are consistent with peer-reviewed research published in ACS Omega ("Ultrahigh Temperature Purification of Graphite for the Development of a Continuous Process," ACS Omega, 2025), conducted by American Energy Technologies Company ("AETC") and NRCan, which demonstrated that ultrahigh-temperature purification of natural Canadian graphite can produce materials exhibiting purity and crystallinity suitable for advanced applications. Focus's ongoing testwork indicates that residual impurities appear primarily on the surface of the graphite flake—as evidenced by ultra-fine features observed through scanning electron microscopy—suggesting that purification efficiency is strongly influenced by surface cleaning dynamics rather than structural defects within the carbon lattice.Dean Hanisch, Chief Executive Officer of Focus commented, "These results validate Lac Knife as one of the rare unique natural graphite deposits capable of competing in high margin advanced technological markets and as a potential alternative to synthetic materials that are more expensive and have a larger environmental impact. With support from Canada's Federal Government, through Natural Resources Canada's Global Partnerships Initiative, we are now positioned to accelerate our scale-up work and unlock commercial pathways across nuclear energy, defense systems, graphene production, and next-generation electronics."Lac Knife graphite's combination of ultra-high purity and large flake distribution positions it for a range of advanced industrial, clean energy, and high-technology applications.Unlocking Advanced Markets Beyond NuclearBeyond nuclear applications, the ultra-high purity and medium-grain morphology of Lac Knife graphite position the material as a strategic feedstock for several advanced technology markets facing supply shortages, performance bottlenecks, and increasing scrutiny over material purity.Graphene & Few-Layer Graphene (FLG) ProductionIn the graphene sector, precursor quality is the primary determinant of performance. Impurities commonly found in natural graphite—typically 0.5-1 microns in size, or roughly one thousand (1000) times thicker than a graphene layer—are known to disrupt electrical, thermal, and mechanical properties unless fully removed. Lac Knife's 5N+ purity eliminates these defects at the source, allowing the flake to exfoliate cleanly into high-value graphene structures.Peer-reviewed research published in Carbon ("Influence of graphite geography on the yield of mechanically exfoliated few-layer graphene," Carbon, 2023) demonstrates the significance of geological origin in FLG production. In follow-on AETC—Yale University testing based on the methodologies outlined in that study, Lac Knife graphite achieved a record-high few-layer graphene yield of 22% ± 3%, outperforming all other natural samples evaluated and showing exfoliation behavior that synthetic graphite could not replicate.Taken together, these results position Lac Knife as one of the few North American natural flake sources capable of supplying advanced graphene markets, including conductive coatings, EMI-shielding materials, flexible electronics, sensors, and next-generation energy storage systems.Defence: IR Obscuration & Countermeasure SystemsThe defence sector presents another major opportunity. Modern warfare increasingly requires materials capable of obscuring both visible and infrared signatures. Traditional obscurants—such as bronze flakes, titanium dioxide, and red phosphorus—pose toxicity, safety, and performance challenges. High-purity graphite and graphene derived from Lac Knife offer a lightweight, non-toxic, and thermally stable alternative capable of generating rapid-dispersion and longer-lasting obscurant clouds.These materials are applicable to 40 mm muzzle-blast cartridges, airburst obscuration rounds for UAVs and rotorcraft, countermeasure dispenser systems, and naval surface-ship defence platforms. The U.S. Department of War currently procures graphene-based obscurants at approximately US$30,000 per ton, reflecting both strategic importance and limited supply. Lac Knife's purity is essential here, as impurities directly interfere with graphene formation and degrade obscurant performance.Stealth Coatings & Electromagnetic Protection SystemsUltra-high purity graphite also plays a critical role in stealth coatings and electromagnetic protection systems. Engineered systems operating across the 400 MHz to 30 GHz spectrum require materials that deliver highly reproducible electrical conductivity, thermal stability, and particle uniformity.These coatings and composites are used in radar-absorbing structures for stealth UAVs, thermal-vision targeting systems, and a range of low-observable technologies. Because deviations in graphite purity can compromise system reliability or operator safety, defence and shielding markets pay substantial premiums—often up to US$50,000 per ton—for 5N-grade material. Lac Knife's combination of purity, consistency, and grain structure aligns closely with these stringent requirements and allows for further refinement into fine, superfine, ultrafine, or microfine grades without compromising integrity.Critical Infrastructure Hardening (HEMP, IEMI and Geomagnetic Storms)The same purity advantages extend into critical infrastructure protection. As governments and utilities work to harden electrical grids, substations, and 5G networks against high-altitude electromagnetic pulses (HEMP), intentional electromagnetic interference (IEMI), and severe geomagnetic storms, materials must perform reliably across high-frequency ranges and under extreme operating conditions.Graphite-based shielding and coatings designed for these systems rely on predictable, reproducible material behavior—standards that only ultra-high purity graphite can meet. Lac Knife's 5N+ output offers the reliability required for these mission-critical applications.Additional High-Value Markets Enabled by 5N+ PurityIn addition to these strategic sectors, Lac Knife's purity profile and particle characteristics also unlock potential in several high-value industries, including thermal management components for semiconductors and LEDs, high-pressure synthetic diamond production, PEM and SOFC fuel-cell bipolar plates, and laboratory-grade graphite consumables where contamination must be tightly controlled. In each of these markets, ultra-high purity reduces defects, increases stability, and improves overall system performance, enabling natural graphite to compete directly with synthetic alternatives.Next Steps in Technical ValidationFocus is advancing a comprehensive technical qualification program to further define Lac Knife's suitability for nuclear and advanced material markets. Ongoing nuclear graphite testing includes detailed characterization of particle size distribution, compressibility, electrical resistivity, and coefficient of friction—parameters that determine whether a graphite material can perform reliably under the thermal, mechanical, and irradiation stresses present in high-temperature reactor environments. The Company expects to fabricate and evaluate near-net-shape graphite bricks, an essential step toward assessing Lac Knife material in full-scale core component geometries and within ASME Division 5 design criteria.In parallel, Focus is extending its validation program—supported through NRCan's Global Partnerships Initiative ("GPI")—advanced materials markets. Current work programs under consideration include assessing Lac Knife graphite as a precursor for high-yield graphene, nano-wafer substrates, thin-film semiconductors, next-generation electronic components, and aerospace composites, including unmanned aerial systems (UAS). These sectors demand highly reproducible, ultra-high-purity carbon materials traditionally sourced from synthetic graphite. Early results indicate that Lac Knife's 5N+ natural graphite may offer a technically competitive—and potentially more sustainable—North American alternative to synthetic feedstocks across multiple high-value applications.ElementImpurity Limit (mg/kg)EBC FactorEBC CalculationAg0.050.00830.000415Al10.00010.0001B0.1210.12Ca0.360.00020.000072Cd50.31721.586Cl1.50.01340.0201Co0.050.00890.00445Cr0.120.00080.000096Cu0.250.00080.0002Dy0.050.08180.00409Eu0.10.4250.0425Fe0.210.00060.000126Gd0.054.39910.219955K0.60.00080.00048Li0.030.14390.004317Mn0.120.00340.000408Mo0.150.00040.00006Na0.0850.00030.0000255Ni0.180.00110.00198S1.40.00020.00028Si1.460.00010.000146Sm0.050.53360.02668Th0.010.00050.000005Ti0.530.00180.000954U0.050.00050.000025V0.080.00140.000112 Total 2.0277895 Table 1: EBC Calculation, Thermally Purified Lac Knife Lot ID: GN250730005Figure 1: Particle Size Distribution, Thermally Purified Lac Knife Lot ID: GN250730005To view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/1963/277711_279dc9a07490cbe0_001full.jpgTap DensityScott VolumeSurface AreaLOI g/ccg/ccm2 /gWt. % C0.60.41.499.9996 Table 2: Data, Thermally Purified Lac Knife Lot ID: GN250730005% TileSize (um)D10105.2D50337.3D90673.8MV368.5 Table 3: Data (2), Thermally Purified Lac Knife Lot ID: GN250730005Qualified PersonDr. Joseph Doninger, Director of Technology and Manufacturing for Focus Graphite, is the Qualified Person ("QP") as defined under National Instrument 43-101 - Standards of Disclosure for Mineral Projects. Dr. Doninger has reviewed and approved the technical information contained in this news release. Dr. Doninger is a chemical engineer and the developer or co-developer of multiple U.S., European, and Canadian patents relating to carbon processing technologies and purification equipment. He has authored or co-authored more than two dozen technical papers and studies on graphite composite anodes, carbon-based materials for electrochemical energy storage systems, and advanced graphite for lithium-ion batteries.About Focus Graphite Advanced Materials Inc. Focus Graphite Advanced Materials is redefining the future of critical minerals with two 100% owned world-class graphite projects and cutting-edge battery technology. Our flagship Lac Knife project stands as one of the most advanced high-purity graphite deposits in North America, with a fully completed feasibility study. Lac Knife is set to become a key supplier for the battery, defense, and advanced materials industries.Our Lac Tetepisca project further strengthens our portfolio, with the potential to be one of the largest and highest-purity and grade graphite deposits in North America. At Focus, we go beyond mining - we are pioneering environmentally sustainable processing solutions and innovative battery technologies, including our patent-pending silicon-enhanced spheroidized graphite, designed to enhance battery performance and efficiency.Our commitment to innovation ensures a chemical-free, eco-friendly supply chain from mine to market. Collaboration is at the core of our vision. We actively partner with industry leaders, research institutions, and government agencies to accelerate the commercialization of next-generation graphite materials. As a North American company, we are dedicated to securing a resilient, locally sourced supply of critical minerals - reducing dependence on foreign-controlled markets and driving the transition to a sustainable future.For more information on Focus Graphite Inc. please visit http://www.focusgraphite.com.LinkedIn: https://www.linkedin.com/company/focus-graphite/ X: https://x.com/focusgraphiteInvestors Contact: Dean Hanisch CEO, Focus Graphite Inc. dhanisch@focusgraphite.com +1 (613) 612-6060Jason LatkowcerVP Corporate Developmentjlatkowcer@focusgraphite.comCautionary Note Regarding Forward-Looking StatementsCertain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words "could," "intend," "expect," "believe," "will," "projected," "estimated," and similar expressions, as well as statements relating to matters that are not historical facts, are intended to identify forward-looking information and are based on the Company's current beliefs or assumptions as to the outcome and timing of such future events.In particular, this press release contains forward-looking information regarding, among other things, the anticipated performance and downstream applicability of ultra-high-purity graphite derived from the Lac Knife project; the potential for 5N+ purification results and nuclear-grade Equivalent Boron Concentration ("EBC") values to be replicated at larger scale; the implications of testwork conducted under Natural Resources Canada's Global Partnerships Initiative ("GPI") and the expected outcomes of related engineering, scale-up, and validation programs; the ability of Lac Knife graphite to meet nuclear, graphene, defense, electromagnetic shielding, thermal management, semiconductor, and other advanced material specifications; the potential commercial pathways associated with supplying high-purity natural graphite as an alternative to synthetic graphite; and the Company's strategy to position itself within North American supply chains for clean energy, advanced manufacturing, aerospace, and critical infrastructure markets.Forward-looking statements are subject to known and unknown risks, uncertainties, and other factors that may cause actual results, performance, or achievements to differ materially from those expressed or implied by such statements. These risks and uncertainties include, but are not limited to, risks related to market conditions, regulatory approvals, changes in economic conditions, the ability to raise sufficient funds on acceptable terms or at all, operational risks associated with mineral exploration and development, and other risks detailed from time to time in the Company's public disclosure documents available under its profile on SEDAR+.The forward-looking information contained in this release is made as of the date hereof, and the Company is not obligated to update or revise any forward-looking information, whether as a result of new information, future events, or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties, and assumptions contained herein, investors should not place undue reliance on forward-looking information.Neither TSX Venture Exchange nor its Regulation Services accepts responsibility for the adequacy or accuracy of this release.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/277711 Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
Pemimpin pembangkang Venezuela Machado muncul semula di Norway selepas beberapa bulan bersembunyi kewangan

Pemimpin pembangkang Venezuela Machado muncul semula di Norway selepas beberapa bulan bersembunyi

Disember 10, 2025
(SeaPRwire) - María Corina Machado muncul di khalayak ramai pada Khamis buat kali pertama dalam 11 bulan di Norway apabila anak perempuannya menerima anugerah Hadiah Keamanan Nobel bagi pihaknya.Machado telah bersembunyi sejak 9 Januari, apabila dia ditahan seketika selepas menyertai penyokongnya di ibu kota Venezuela, Caracas. Pengiktirafan beliau datang selepas melancarkan cabaran aman terhadap kerajaan Presiden Venezuela Nicolás Maduro.Orang ramai melaungkan, "Kebebasan!" apabila Machado melangkah ke balkoni hotel di Oslo, Norway, dan melambai kepada penyokongnya sebelum menyanyikan lagu kebangsaan Venezuela bersama mereka.Dalam rakaman audio panggilan telefon yang diterbitkan di laman web Nobel, Machado berkata dia tidak akan dapat tiba ke Oslo tepat pada masanya untuk majlis penyampaian anugerah, tetapi ramai orang telah "mempertaruhkan nyawa mereka" untuk membawanya ke sana."Saya sangat berterima kasih kepada mereka, dan ini adalah ukuran tentang apa yang pengiktirafan ini bermakna untuk rakyat Venezuela," katanya.Anak perempuannya, Ana Corina Sosa, menerima Hadiah Nobel sebagai gantinya, sambil berkata bahawa ibunya "ingin hidup di Venezuela yang bebas" dan "tidak akan pernah berputus asa terhadap tujuan itu.""Itulah sebabnya kita semua tahu, dan saya tahu, bahawa dia akan kembali ke Venezuela tidak lama lagi," tambah Sosa.Di luar hotel, Machado berinteraksi dan memeluk orang ramai, sementara mereka mengambil gambar dan memujinya dengan laungan "Presiden! Presiden!""Saya mahu kamu semua kembali ke Venezuela," kata Machado.Kemunculan Machado berlaku selepas Presiden pada Rabu mengumumkan AS merampas sebuah kapal tangki minyak Venezuela, satu langkah yang boleh memburukkan lagi hubungan dengan kerajaan Maduro, yang sudah pun tertakluk kepada sekatan AS yang meluas terhadap sektor minyak negara itu.Sejak September, telah mensasarkan individu yang didakwa pengedar dadah berhampiran Venezuela sekurang-kurangnya 22 kali, membunuh 87 orang. Trump juga baru-baru ini berkata "hari-hari Maduro sudah bernombor" dan enggan menolak kemungkinan operasi darat di Venezuela.Steve Yates, felo penyelidikan kanan bagi dasar China dan keselamatan negara di The Heritage Foundation, berkata dalam " @ Night" pada Rabu bahawa lawatan Machado di luar negara adalah peluang untuk mendapatkan "sokongan antarabangsa yang lebih besar" untuk perjuangannya, sambil menambah bahawa Trump mungkin mendapat manfaat dengan mempunyai lebih banyak sekutu Amerika di Eropah menyokong pendekatan "bukan pencerobohan".Pemimpin pembangkang Venezuela itu sebelum ini telah lantang menyokong terhadap rejim Maduro dan rangkaian pengedaran dadah negara itu.Selepas anugerah itu diumumkan pada Oktober, pemenang baharu Hadiah Keamanan Nobel itu mendedikasikan anugerah tersebut kepada Trump dan "rakyat Venezuela yang menderita".Machado berkata dalam satu temu bual "Fox & Friends Weekend" bulan lepas bahawa Venezuela sedang berada di "," sambil menekankan "manifesto kebebasan" barunya yang membayangkan masa depan tanpa rejim Maduro. Digital's Morgan Phillips dan Artikel ini disediakan oleh pembekal kandungan pihak ketiga. SeaPRwire (https://www.seaprwire.com/) tidak memberi sebarang waranti atau perwakilan berkaitan dengannya. Sektor: Top Story, Berita Harian SeaPRwire menyampaikan edaran siaran akhbar secara masa nyata untuk syarikat dan institusi, mencapai lebih daripada 6,500 kedai media, 86,000 penyunting dan wartawan, dan 3.5 juta desktop profesional di seluruh 90 negara. SeaPRwire menyokong pengedaran siaran akhbar dalam bahasa Inggeris, Korea, Jepun, Arab, Cina Ringkas, Cina Tradisional, Vietnam, Thai, Indonesia, Melayu, Jerman, Rusia, Perancis, Sepanyol, Portugis dan bahasa-bahasa lain.
More
Dr. Teck Lim Chia, Chairman and CEO of CBL International, Honored at the Prestigious Directors of the Year Awards ACN Newswire

Dr. Teck Lim Chia, Chairman and CEO of CBL International, Honored at the Prestigious Directors of the Year Awards

Disember 10, 2025
KUALA LUMPUR, December 11, 2025 - (ACN Newswire via SeaPRwire.com) – CBL International Limited (NASDAQ: BANL) (the “Company” or “CBL”), the listing vehicle of the Banle Group (“Banle” or “the Group”) is honored to announce that Dr. Teck Lim Chia, Chairman and Chief Executive Officer of CBL International Limited, has been selected as an Awardee in the Directors of the Year Awards – Listed Companies Executive Directors category, presented by the Hong Kong Institute of Directors (HKIoD).This esteemed accolade follows a comprehensive evaluation by an independent panel of judges comprising senior business leaders, governance experts, and institutional investors. The award recognizes Dr. Chia’s outstanding contributions to corporate governance, exemplary board leadership, and his proven track record in driving sustainable value creation for shareholders and stakeholders.The HKIoD Directors of the Year Awards are among Asia’s most respected honors in corporate governance. Awardees are chosen based on demonstrated excellence in strategic oversight, ethical leadership, transparency, and long-term sustainable performance—all hallmarks of Dr. Chia’s tenure at CBL International. As Chairman and CEO, Dr. Chia has led the Group through a period of transformative growth while embedding governance excellence into the company’s core. Under his stewardship, CBL has strengthened its investor relations framework, enhanced ESG disclosures, deepened stakeholder engagement, and maintained rigorous compliance with international standards throughout its expansion across Asia Pacific, Europe, Central America and Africa.In accepting the award, Dr. Teck Lim Chia said: “I am deeply humbled and grateful to receive this prestigious recognition from the Hong Kong Institute of Directors. This honor belongs not to me alone, but to our entire board, management team, and employees who share a relentless commitment to integrity, innovation, and responsible growth. At CBL, we believe governance is not a box to check — it is the compass that guides every decision. I will continue to lead with purpose, accountability, and vision, always placing the long-term interests of our stakeholders first.”The Board of CBL International expressed its pride in Dr. Chia’s achievement: “Dr. Chia’s leadership has been instrumental in shaping CBL into a globally recognized, governance-forward enterprise. His ability to balance strategic ambition with disciplined oversight exemplifies what modern corporate leadership should be. We congratulate him on this well-deserved honor.”Photo caption: Dr. Teck Lim Chia (right), Chairman and CEO of CBL International Limited, honored at the Directors of the Year Awards – Listed Companies Executive Directors category by the Hong Kong Institute of Directors (HKIoD).Photo caption: The trophy for Directors of the Year Awards – Listed Companies Executive Directors category by the Hong Kong Institute of Directors (HKIoD).About the Banle GroupCBL International Limited (Nasdaq: BANL) is the listing vehicle of Banle Group, a reputable marine fuel logistics company based in the Asia Pacific region that was established in 2015. We are committed to providing customers with a one-stop solution for vessel refueling, which is referred to as bunkering facilitator in the bunkering industry. We facilitate vessel refueling mainly through local physical suppliers in 65 major ports covering Belgium, China, Hong Kong, India, Japan, Korea, Malaysia, Mauritius, Panama, the Philippines, Singapore, Taiwan, Thailand, Turkey and Vietnam. The Group actively promotes the use of sustainable fuels and has been awarded the ISCC EU and ISCC Plus certifications.For more information about our Company, please visit our website at: https://www.banle-intl.com. Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More

Cloudbreak Pharma Soars 80%+ on Multiple Catalysts, Driving Value Re-Rating

Disember 10, 2025
HONG KONG, December 11, 2025 - (ACN Newswire via SeaPRwire.com) – Since 2025, driven by both policy tailwinds and fundamental strengths, the innovative drug sector in the Hong Kong stock market has experienced a valuation recovery. Although it experienced some correction in the second half due to external environmental factors, its overarching growth logic remains intact. Institutional analysis indicates that innovative drugs continue to represent the clearest industry trend within the pharmaceutical sector, with promising development prospects ahead.Among the players, Cloudbreak Pharma (2592.HK), a biotech company focused on ophthalmology, has recently demonstrated strong stock performance. As of December 9, its share price closed at HK$8.24, having accumulated a gain of over 80% in approximately two weeks, and making it a standout "star stock" in the capital markets. This impressive performance is not coincidental but rather the inevitable result of multiple positive catalysts converging, including breakthroughs in its core product pipeline, enhancements to its global intellectual property (IP) layout, and an upgrade of its core management team.Securing Another Victory in Patent Layout, Accelerating Commercialization of Core ProductOn November 27, Cloudbreak Pharma's wholly-owned subsidiary, ADS Therapeutics LLC, successfully secured two core patents in Japan and Europe. Both patents relate to ophthalmic topical compositions and their uses for the core product CBT-009, laying a legal foundation for its global commercialization.As a novel atropine ophthalmic formulation for treating myopia in children and adolescents aged 5 to 19, CBT-009, with its unique non-aqueous formulation design, demonstrates potential advantages over traditional aqueous formulations in terms of drug stability, safety, and patient tolerability, positioning it as a potential best-in-class product. Currently, the product's development is progressing steadily. It received U.S. FDA approval to initiate Phase 3 clinical trial in September 2024. Juvenile animal toxicity studies in China commenced in February 2025, and preparations for Phase 3 clinical trial are actively underway.The grant of these patents in Japan and Europe not only strengthens the global IP portfolio for CBT-009, but will also accelerate its commercialization process. Leveraging patent protection, the Company has the potential to establish partnerships with global pharmaceutical giants to advance the product's production and distribution in key markets like Japan and Europe, accelerating global market penetration. Given the severity of the global adolescent myopia issue, CBT-009 is expected to become a core engine for the Company's future performance growth.Pipeline Progress Across Multiple Fronts; CBT-004 Advances Towards Phase 3Beyond CBT-009, another promising drug candidate from Cloudbreak Pharma, CBT-004, has also reached a significant milestone. As a potential first-in-class drug for vascularized pinguecula, CBT-004 uses Multi-Kinase Inhibitor targeting Vascular Endothelial Growth Factor Receptor (VEGFR) and Platelet-Derived Growth Factor Receptor (PDGFR). According to the Company's latest disclosures, CBT-004 yielded positive results in a Phase 2 clinical trial evaluating its safety and efficacy in treating pinguecula. The Company has begun advancing its Phase 3 clinical development and is scheduled to meet with the United States Food and Drug Administration (the “FDA”) on December 10 (Pacific Standard Time, PST) at an End-of-Phase 2 meeting to establish a regulatory pathway for potential approval.It is understood that there are currently no approved drugs globally specifically for treating vascularized pinguecula. Existing treatment options mostly offer temporary symptomatic relief, leaving significant unmet clinical needs. Should CBT-004 successfully complete development and gain approval, it would become the first targeted therapy, rapidly capturing market share with its unique efficacy advantages. This would create a new revenue stream for the Company while further solidifying its leading position in the field of ophthalmic innovative drugs.Strengthened Executive Team Elevates Commercialization CapabilitiesThe success of innovative drugs relies not only on R&D prowess but also on robust commercialization capabilities to realize their value. On December 1, 2025, Cloudbreak Pharma announced the official appointment of Mr. Michael Rowe as its new Chief Business Officer (CBO), injecting key momentum into the Company's global commercial strategy.Public information shows that Mr. Michael Rowe possesses substantial hands-on commercialization experience across senior management, marketing, sales management, and clinical operations. He is particularly skilled in driving organizational efficiency and achieving breakthroughs in innovative business areas. His industry resources and operational capabilities are expected to bring comprehensive enhancements to the Company.This executive appointment coincides with Cloudbreak Pharma’s core products entering a critical preparatory phase for commercialization. Mr. Michael Rowe's joining will strengthen the Company's business development capabilities in European and American markets, accelerating the construction of its global commercial footprint. Currently, through collaborations with companies such as Grand Pharmaceutical Group and Santen, Cloudbreak Pharma has established a commercialization foundation in Greater China and the Asia-Pacific region (excluding China). With the new CBO onboard, the Company is poised to further expand its global partnership network, optimize commercialization strategies, and provide robust support for the market entry of its multiple core products.With Sustained High Industry Growth, Valuation Re-rating Potential RemainsIn recent years, the global incidence of ophthalmic diseases has continued to rise. Conditions like pterygium and adolescent myopia affect hundreds of millions of patients, while the supply of innovative drugs in related treatment areas remains severely inadequate, indicating a vast unmet market need. Concurrently, governments worldwide are increasing support for pharmaceutical innovation, providing a favorable policy environment for high-quality innovative drug companies. Within the Hong Kong stock market, the innovative drug sector is experiencing a favorable trend of valuation re-rating. Companies with solid R&D pipelines, clear commercialization pathways, and core competitiveness are seeing gradually rising valuation expectations.As an innovative drug company dedicated to ophthalmology, Cloudbreak Pharma has built a rich pipeline covering 8 drug candidates targeting major diseases in both the anterior and posterior segments of the eye, forming a diversified product matrix. With steady progress in R&D and an increasingly refined global commercialization strategy, the Company already exhibits scarce growth attributes. The recent short-term surge in its stock price, catalyzed by multiple positive factors, is merely the beginning of value release. As these favorable initiatives are further implemented and pipeline value continues to be realized, Cloudbreak Pharma is poised to achieve dual enhancement in both performance and valuation. Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
Pengilang Cat Mowilex Menerima Pengiktirafan ‘Best Managed Company’ Keempat Deloitte, Mencapai Gold Standard Berita

Pengilang Cat Mowilex Menerima Pengiktirafan ‘Best Managed Company’ Keempat Deloitte, Mencapai Gold Standard

Disember 10, 2025
(SeaPRwire) - Sorotan Berita Utama: Pengiktirafan Mowilex untuk kali keempat berturut-turut sebagai Syarikat Tertadbir Terbaik Indonesia telah meningkatkannya sebagai pemenang Gold Standard, mengukuhkan komitmennya terhadap pengurusan dan prestasi terbaik dalam kelasnya, selaras dengan kepimpinan yang kukuh bersama inovasi dan penciptaan nilai jangka panjang. Mowilex melihat pengiktirafan ini sebagai peringatan berterusan untuk terus berusaha mencapai kecemerlangan, dan sebagai pencapaian yang perlu dikongsi dengan semua orang yang telah menjadi sebahagian daripada perjalanan Mowilex. JAKARTA, Indonesia, 10 Dis 2025 — PT Mowilex Indonesia sekali lagi dianugerahkan oleh Deloitte sebagai salah satu Syarikat Tertadbir Terbaik Indonesia, menandakan tahun keempat berturut-turut menerima pengiktirafan ini. Ini juga bermakna Mowilex kini telah dinaik taraf sebagai pemenang Gold Standard, menekankan komitmen berterusannya terhadap pengurusan dan prestasi terbaik dalam kelasnya. Di Indonesia, hanya tiga syarikat yang dianugerahkan pengiktirafan Gold Standard tahun ini, dan Mowilex bangga menjadi salah satu daripadanya. Program Best Managed Companies secara meluas dianggap sebagai penanda aras kecemerlangan organisasi untuk syarikat-syarikat terkemuka di seluruh dunia. “Sebagai pemenang anugerah Best Managed Companies, PT Mowilex Indonesia telah menunjukkan dirinya sebagai perusahaan swasta terkemuka di Indonesia—mengerakkan pertumbuhan mampan, menggalakkan inovasi, dan memberi impak bermakna kepada pelanggan dan pekerjanya. Pengiktirafan ini adalah bukti kecemerlangan, menekankan kepimpinan dan visi strategik PT Mowilex Indonesia. Kami menantikan untuk menyaksikan kejayaan dan pertumbuhan berterusan mereka di Indonesia dan di pentas global,” kata DIONISIUS Damijanto, Ketua Best Managed Companies, Deloitte Indonesia. Mowilex menekankan bahawa pengiktirafan ini berfungsi sebagai peringatan untuk kekal rendah hati dan terus berusaha mencapai kecemerlangan. “Kami adalah pencabar bebas dalam industri yang didominasi oleh multinasional besar dan segelintir pemain tempatan yang diuruskan dengan sangat baik. Setiap tahun, proses Deloitte mencabar kami dengan ulasan yang ketat dan soalan-soalan sukar. Daripada menganggap pengiktirafan ini sebagai pengesahan, kami menganggapnya sebagai ujian — menanyakan sama ada strategi dan taktik kami masih akan tahan di bawah pengawasan sedemikian,” kata Ketua Pegawai Eksekutif Mowilex, Niko Safavi. Pemenilai dinilai berdasarkan rangka kerja komprehensif yang dibentuk oleh lebih 30 tahun penanda aras global Deloitte, iaitu: strategi, budaya dan komitmen, keupayaan dan inovasi, tadbir urus dan kewangan. Rangka kerja ini menggalakkan syarikat untuk menyelaraskan kepimpinan yang kukuh dengan inovasi dan penciptaan nilai jangka panjang. Mowilex juga menekankan bahawa pengiktirafan ini bukan hanya tentang kepimpinan individu semata-mata. “Ini adalah anugerah pengurusan yang menjadi milik pengurus dan pekerja kami. Disiplin, inovasi, dan keputusan harian merekalah yang membentuk PT Mowilex Indonesia menjadi apa yang ada pada hari ini. Kami dengan bangganya berkongsi pencapaian Gold Standard ini dengan semua orang yang telah menjadi sebahagian daripada perjalanan kami,” kata Niko Safavi. Mengenai PT Mowilex Indonesia PT Mowilex Indonesia, anak syarikat Asia Coatings Enterprises, Pte. Ltd., adalah pengeluar cat dan salutan premium terkemuka dengan reputasi untuk kualiti dan kesetiaan jenama yang kuat. Syarikat ini adalah pengeluar cat neutral karbon bersijil tunggal di Indonesia, mengekalkan status tersebut selama enam tahun berturut-turut, dan menawarkan pelbagai produk VOC rendah dan sifar. Pada tahun 2025, Mowilex telah diiktiraf oleh Deloitte sebagai salah satu Syarikat Tertadbir Terbaik Indonesia untuk kali keempat berturut-turut, menjadi pemenang Gold Standard. Mengenai Best Managed Companies Best Managed Companies adalah program anugerah global yang mengiktiraf syarikat swasta untuk kecemerlangan organisasi, kejayaan perniagaan, dan semangat keusahawanan. Program ini menawarkan rangka kerja yang kukuh untuk pasukan pengurusan menilai strategi mereka, mengukuhkan operasi, dan menanda aras diri mereka terhadap syarikat swasta terbaik di seluruh dunia. Ditubuhkan di Kanada pada tahun 1993, Best Managed Companies telah berkembang ke lebih 45 negara merentasi Asia Pasifik, Amerika, Eropah, dan Timur Tengah, dengan rancangan untuk dilancarkan di Afrika. Hari ini, rangkaian globalnya terdiri daripada lebih 1,700 syarikat cemerlang yang bersatu sebagai komuniti untuk membina pakatan, bertukar pengetahuan, dan berkongsi amalan terbaik. Pada tahun 2025, program anugerah Best Managed Companies menandakan lima tahun di Asia Tenggara, dengan komuniti pemenang di Indonesia, Malaysia, Singapura, Thailand dan Vietnam. Untuk maklumat lanjut tentang program anugerah ini, lawati Photo – Photo – Artikel ini disediakan oleh pembekal kandungan pihak ketiga. SeaPRwire (https://www.seaprwire.com/) tidak memberi sebarang waranti atau perwakilan berkaitan dengannya. Sektor: Top Story, Berita Harian SeaPRwire menyampaikan edaran siaran akhbar secara masa nyata untuk syarikat dan institusi, mencapai lebih daripada 6,500 kedai media, 86,000 penyunting dan wartawan, dan 3.5 juta desktop profesional di seluruh 90 negara. SeaPRwire menyokong pengedaran siaran akhbar dalam bahasa Inggeris, Korea, Jepun, Arab, Cina Ringkas, Cina Tradisional, Vietnam, Thai, Indonesia, Melayu, Jerman, Rusia, Perancis, Sepanyol, Portugis dan bahasa-bahasa lain.
More
VisIC Technologies Mengumumkan $26 juta Pendanaan Putaran B Dipimpin oleh Pimpinan Semikonduktor Global; Hyundai Motor Company dan Kia (Bersama sebagai “HKMC”) Bergabung sebagai Pelabur Strategik Berita

VisIC Technologies Mengumumkan $26 juta Pendanaan Putaran B Dipimpin oleh Pimpinan Semikonduktor Global; Hyundai Motor Company dan Kia (Bersama sebagai “HKMC”) Bergabung sebagai Pelabur Strategik

Disember 10, 2025
(SeaPRwire) - NESS ZIONA, Israel, 10 Disember 2025 — VisIC Technologies Ltd., peneroka dalam semikonduktor kuasa Gallium Nitride (GaN) untuk mobiliti elektrik, hari ini mengumumkan penutupan kedua yang berjaya bagi pembiayaan Round Bnya, memperoleh $26 juta. Pusingan ini dipimpin oleh pemandu semikonduktor global, dengan HKMC bergabung sebagai pelabur strategik. Milestone ini mengukuhkan kedudukan VisIC di barisan hadapan inovasi GaN untuk penyongsang tarikan EV dan menguatkan peranannya dalam membolehkan mobiliti elektrik generasi seterusnya. Fokus pelabur utama untuk memajukan teknologi semikonduktor kritikal melengkapkan platform proprietari VisIC D³GaN, yang direka untuk memberikan kecekapan, kebolehskalaan, dan kebolehpercayaan yang tiada tandingan untuk driveline automotif. Penyertaan HKMC menekankan komitmennya untuk menyepadukan teknologi GaN ke dalam platform EV pengeluaran besar-besaran. Pasaran EV global sedang mengalami pertumbuhan pesat, dengan pembuat kenderaan berlumba-lumba untuk meningkatkan jarak pandu, mengurangkan kos, dan memenuhi sasaran kelestarian yang lebih ketat. Halangan kritikal terletak pada kecekapan dan kebolehskalaan elektronik kuasa, khususnya penyongsang tarikan, yang memberi kesan langsung kepada prestasi kenderaan dan penggunaan tenaga. Pernyataan MasalahPenyelesaian berasaskan silikon tradisional menghadapi kesukaran untuk memberikan kecekapan dan ketumpatan kuasa yang diperlukan untuk platform EV generasi seterusnya, khususnya pada voltan yang lebih tinggi. Walaupun peranti SiC (Silicon Carbide) menawarkan prestasi yang lebih baik, kos yang tinggi dan pembuatan yang kompleks mengehadkan penerimaan meluas. Teknologi D³GaN VisIC yang berasaskan GaN mengatasi batasan ini dengan membolehkan penyongsang yang lebih kecil, ringan, dan lebih cekap—membuka kemungkinan baru untuk kedua-dua arkitektur 400V dan 800V. Penggunaan DanaDana baru akan mempercepatkan pelan VisIC, termasuk: Pengoptimuman, kelayakan, dan pelepasan dice GaN 750V Gen3 dan modul kuasa. Pembangunan teknologi GaN 1350V Gen4, menyokong spektrum penuh reka bentuk EV. Penstabilan rantaian bekalan dan peningkatan penghantaran produk GaN untuk penyongsang tarikan EV. Pembangunan ke dalam keperluan kuasa pusat data 800V yang muncul, dengan memanfaatkan platform GaN canggih yang sama. Kenyataan EksekutifTamara Baksht, CEO VisIC Technologies:“Pelaburan ini menandakan milestone utama untuk VisIC dan industri EV global. Teknologi D³GaN kami sedang mentakrif semula elektronik kuasa untuk kenderaan elektrik, dan sokongan daripada rakan strategik kami mempercepatkan misi kami untuk menyediakan penyelesaian yang cekap tinggi dan boleh skala untuk mobiliti generasi seterusnya.” Hyundai Motor Company dan Kia:“Hyundai Motor Company dan Kia komited untuk memajukan mobiliti lestari. Kerjasama dengan VisIC membolehkan kami menyepadukan teknologi kuasa GaN canggih ke dalam platform EV kami, meningkatkan kecekapan, kebolehpercayaan, dan prestasi semasa kami membentuk masa depan pengangkutan elektrik.” Hubungi: Dieter Liesabeths Logo: Artikel ini disediakan oleh pembekal kandungan pihak ketiga. SeaPRwire (https://www.seaprwire.com/) tidak memberi sebarang waranti atau perwakilan berkaitan dengannya. Sektor: Top Story, Berita Harian SeaPRwire menyampaikan edaran siaran akhbar secara masa nyata untuk syarikat dan institusi, mencapai lebih daripada 6,500 kedai media, 86,000 penyunting dan wartawan, dan 3.5 juta desktop profesional di seluruh 90 negara. SeaPRwire menyokong pengedaran siaran akhbar dalam bahasa Inggeris, Korea, Jepun, Arab, Cina Ringkas, Cina Tradisional, Vietnam, Thai, Indonesia, Melayu, Jerman, Rusia, Perancis, Sepanyol, Portugis dan bahasa-bahasa lain.
More
BillionToOne Melantik Anthony Pagano ke Lembaga Pengarah sebagai Pengerusi Jawatankuasa Audit Berita

BillionToOne Melantik Anthony Pagano ke Lembaga Pengarah sebagai Pengerusi Jawatankuasa Audit

Disember 10, 2025
(SeaPRwire) - MENLO PARK, Calif., 9 Dis. 2025 – , Inc. (NASDAQ: BLLN), sebuah syarikat diagnostik molekul generasi akan datang yang mempunyai misi untuk mencipta ujian yang berkuasa dan tepat yang boleh diakses oleh semua, hari ini mengumumkan pelantikan Anthony Pagano ke Lembaga Pengarahnya, berkuat kuasa pada 1 Januari 2026. Encik Pagano juga akan berkhidmat sebagai Pengerusi Jawatankuasa Audit. Encik Pagano kini merupakan Ketua Pegawai Kewangan dan Naib Presiden Eksekutif Genmab, sebuah syarikat bioteknologi antarabangsa terkemuka, jawatan yang disandangnya sejak Mac 2020. Beliau menyertai Genmab pada Disember 2007, mewujudkan rekod prestasi yang kukuh dalam memacu prestasi kewangan dan pertumbuhan strategik sepanjang tempoh perkhidmatannya. Sepanjang tempoh Encik Pagano, Genmab telah berkembang daripada hasil tahunan $100 juta kepada lebih $3 bilion, membangunkan, melancarkan dan mengkomersialkan terapi antibodi yang berbeza dan inovatif yang meningkatkan kehidupan pesakit. Sebelum peranannya di Genmab, Encik Pagano berkhidmat sebagai Pengawal Korporat dan Pengarah Kanan Perancangan Perniagaan untuk NovaDel Pharma, sebuah syarikat farmaseutikal khusus yang didagangkan secara awam. Beliau memulakan kerjaya profesionalnya di KPMG LLP, di mana beliau dinaikkan pangkat kepada Pengurus dan menyediakan perkhidmatan perundingan audit serta penggabungan dan pemerolehan kepada pelbagai pelanggan merangkumi syarikat permulaan sehingga korporat Fortune 500 dalam pelbagai industri. Encik Pagano adalah seorang Akauntan Awam Bertauliah dan memegang Ijazah Sarjana Muda dalam Perakaunan dari The College of New Jersey dan Ijazah Sarjana Pentadbiran Perniagaan dari Sekolah Perniagaan Stern di Universiti New York. “BillionToOne berada di barisan hadapan dalam diagnostik tepat, dan saya berasa terhormat untuk menyokong misi penting ini,” kata Anthony Pagano. “Setelah menyaksikan kuasa inovasi dalam sains hayat sepanjang kerjaya saya, saya kagum dengan teknologi dan pasukan BillionToOne. Saya berharap dapat bekerjasama dengan Lembaga dan pengurusan apabila syarikat memasuki fasa pertumbuhan seterusnya.” “Pelantikan Anthony mengukuhkan Lembaga kami dengan ketara,” kata Dr. Oguzhan Atay, pengasas bersama dan CEO BillionToOne serta Pengerusi Lembaga. “Saya percaya kepintaran kewangannya yang mendalam dan kepimpinan terbukti dalam membimbing syarikat sains hayat yang berkembang pesat akan menjadi penting dalam misi kami untuk mencipta sebuah syarikat diagnostik molekul yang mentakrifkan kategori dan transformatif.” Tentang BillionToOneBeribu pejabat di Menlo Park, California, BillionToOne adalah sebuah syarikat diagnostik molekul generasi akan datang yang mempunyai misi untuk mencipta ujian yang berkuasa dan tepat yang boleh diakses oleh semua. Platform pengiraan molekul Templat Pengiraan Kuantitatif (QCT) berpaten syarikat adalah satu-satunya teknologi berbilang yang boleh mengira molekul DNA dengan tepat pada tahap satu molekul. Untuk maklumat lanjut, lawati . Penyata Berorientasi Masa DepanSiaran akhbar ini mengandungi penyata berorientasi masa depan tertentu mengikut undang-undang sekuriti persekutuan. Penyata berorientasi masa depan ini umumnya dikenal pasti dengan perkataan "percaya," "projek," "jangka," "antisipasi," "anggaran," "niat," "strategi," "masa depan," "peluang," "rancangan," "mungkin," "sepatutnya," "akan," "akan menjadi," "akan terus," "kemungkinan besar akan menghasilkan," dan ungkapan serupa. Penyata berorientasi masa depan adalah ramalan, unjuran dan kenyataan lain tentang peristiwa masa depan yang berdasarkan jangkaan dan andaian semasa dan, akibatnya, tertakluk kepada risiko dan ketidakpastian. Penyata berorientasi masa depan dalam siaran akhbar ini termasuk, tetapi tidak terhad kepada, kenyataan mengenai pertumbuhan masa depan syarikat dan kemajuan teknologi diagnostiknya. Kenyataan ini berdasarkan jangkaan, ramalan dan andaian semasa pengurusan, dan hasil serta keputusan sebenar boleh berbeza dengan ketara daripada kenyataan ini disebabkan oleh beberapa faktor, sebahagiannya di luar kawalan BillionToOne. Risiko dan ketidakpastian ini dan tambahan lain boleh menjejaskan hasil kewangan dan operasi BillionToOne dan menyebabkan hasil sebenar berbeza dengan ketara daripada yang ditunjukkan oleh penyata berorientasi masa depan yang dibuat dalam siaran akhbar ini. Risiko dan ketidakpastian ini termasuk yang dibincangkan di bawah tajuk "Faktor Risiko" dan "Perbincangan dan Analisis Pengurusan mengenai Keadaan Kewangan dan Hasil Operasi" dan di tempat lain dalam prospektus BillionToOne yang difailkan dengan Suruhanjaya Sekuriti dan Bursa pada 6 November 2025. Penyata berorientasi masa depan dalam siaran akhbar ini berdasarkan maklumat yang tersedia untuk BillionToOne setakat tarikh ini, dan BillionToOne menolak sebarang kewajipan untuk mengemaskini sebarang penyata berorientasi masa depan yang dibekalkan untuk mencerminkan sebarang perubahan dalam jangkaannya atau sebarang perubahan dalam peristiwa, keadaan, atau keadaan yang mana mana-mana kenyataan sedemikian berdasarkan, kecuali seperti yang diperlukan oleh undang-undang. Penyata berorientasi masa depan ini tidak boleh dijadikan sandaran sebagai mewakili pandangan BillionToOne setakat mana-mana tarikh selepas tarikh siaran akhbar ini. Hubungan Pelabur Hubungan Media SUMBER BillionToOneArtikel ini disediakan oleh pembekal kandungan pihak ketiga. SeaPRwire (https://www.seaprwire.com/) tidak memberi sebarang waranti atau perwakilan berkaitan dengannya. Sektor: Top Story, Berita Harian SeaPRwire menyampaikan edaran siaran akhbar secara masa nyata untuk syarikat dan institusi, mencapai lebih daripada 6,500 kedai media, 86,000 penyunting dan wartawan, dan 3.5 juta desktop profesional di seluruh 90 negara. SeaPRwire menyokong pengedaran siaran akhbar dalam bahasa Inggeris, Korea, Jepun, Arab, Cina Ringkas, Cina Tradisional, Vietnam, Thai, Indonesia, Melayu, Jerman, Rusia, Perancis, Sepanyol, Portugis dan bahasa-bahasa lain.
More
WORLD FOOD TRAVEL ASSOCIATION UMUMKAN PELANCARAN GERAKAN TASTE OF PLACE Berita

WORLD FOOD TRAVEL ASSOCIATION UMUMKAN PELANCARAN GERAKAN TASTE OF PLACE

Disember 10, 2025
(SeaPRwire) - Inisiatif baharu ini menjemput pencinta makanan dan pengembara budaya untuk membantu membina platform pertama di dunia yang didedikasikan untuk budaya kuliner, warisan makanan, dan pengeluar tempatan. PORTLAND, Ore., 9 Dis. 2025 — World Food Travel Association (WFTA) hari ini mengumumkan pelancaran rasmi Taste of Place Movement, satu inisiatif seluruh dunia yang direka untuk melindungi budaya kuliner, meningkatkan pengeluar makanan tempatan, dan menghubungkan orang ramai serta pembekal di mana-mana sahaja dengan pengalaman makanan bermakna yang berasaskan tempat. Taste of Place dilancarkan pada detik genting untuk sektor makanan, perhotelan, dan pelancongan. Di seluruh dunia, cara makanan tradisional terancam oleh tekanan ekonomi, kemerosotan luar bandar, perubahan iklim, dan kehilangan pantas pengetahuan antara generasi. Ramai artisankuliner, pengeluar kecil, dan penjaga budaya kekurangan keterlihatan dan infrastruktur digital yang diperlukan untuk mencapai khalayak baharu. Taste of Place bertujuan untuk mengubah keadaan ini. “Makanan menghubungkan kita semua, namun orang yang melindungi tradisi kuliner sering kali tidak kelihatan,” kata Erik Wolf, pengasas industri pelancongan makanan moden dan Pengarah Eksekutif WFTA. “Kami sedang membina Taste of Place, yang berbeza daripada platform makanan dan perjalanan arus perdana kerana fokus kami adalah keaslian, integriti budaya, dan misi sosial yang tulen. Masih tiada apa-apa yang wujud setakat ini yang memenuhi keperluan pencinta makanan dan warisan kuliner hari ini.” Sokongan Anda Penting Untuk membina platform tersebut, WFTA menjemput individu, pencinta makanan, organisasi, dan pejuang budaya untuk menyokong pembangunan inisiatif ini. Sokongan anda akan membantu membiayai: Satu direktori global pengalaman makanan, pengeluar, artisankuliner, dan perniagaan makanan milik tempatan. Satu ensiklopedia digital budaya kuliner, mendokumentasikan hidangan, bahan, tradisi, dan cerita dari setiap wilayah. Satu majalah global yang mempamerkan komuniti yang terabai dan orang yang menjaga tradisi makanan. Satu hab komuniti di mana anda boleh menyumbang secara langsung kepada kandungan di Taste of Place. Penyokong menikmati keistimewaan yang tidak tersedia untuk orang awam, termasuk keupayaan untuk mencalonkan penjaga warisan kuliner, dan kemudiannya, untuk memaparkan kandungan mereka sendiri sebaik sahaja platform dilancarkan. Bagi penyokong di Amerika Syarikat, sumbangan mungkin boleh ditolak cukai, kerana WFTA adalah sebuah organisasi bukan untung 501(c)(3) berdaftar. Jemputan Global “Taste of Place adalah lebih daripada sekadar platform,” tambah Wolf. “Ia adalah satu gerakan untuk menghormati rasa, kemahiran, dan cerita yang menjadikan setiap tempat unik. Dan ia adalah sesuatu yang anda boleh bantu bina dari bawah.” Ketahui lebih lanjut atau tawarkan sokongan anda pada musim percutian ini di . Perihal World Food Travel Association Ditubuhkan pada 2001, World Food Travel Association (WFTA) adalah pihak berkuasa terkemuka dunia dalam pelancongan makanan dan minuman. Organisasi ini menyediakan pendidikan, penyelidikan, alat, dan panduan strategik kepada destinasi, perniagaan, dan profesional yang ingin membangunkan dan mempamerkan budaya kuliner unik mereka. Misi WFTA adalah untuk bekerjasama dengan pemasar destinasi dan pihak berkepentingan untuk membangunkan dan meraikan tradisi kuliner yang menjadikan setiap tempat istimewa. Ketahui lebih lanjut di Hubungan Media: Erik Wolf di (503) 213-3700 atau SUMBER World Food Travel AssociationArtikel ini disediakan oleh pembekal kandungan pihak ketiga. SeaPRwire (https://www.seaprwire.com/) tidak memberi sebarang waranti atau perwakilan berkaitan dengannya. Sektor: Top Story, Berita Harian SeaPRwire menyampaikan edaran siaran akhbar secara masa nyata untuk syarikat dan institusi, mencapai lebih daripada 6,500 kedai media, 86,000 penyunting dan wartawan, dan 3.5 juta desktop profesional di seluruh 90 negara. SeaPRwire menyokong pengedaran siaran akhbar dalam bahasa Inggeris, Korea, Jepun, Arab, Cina Ringkas, Cina Tradisional, Vietnam, Thai, Indonesia, Melayu, Jerman, Rusia, Perancis, Sepanyol, Portugis dan bahasa-bahasa lain.
More
Dreame TV Lancar Serangan Antarabangsa: Teknologi Mini LED Generasi Baharu Tawan Peringkat Global Berita

Dreame TV Lancar Serangan Antarabangsa: Teknologi Mini LED Generasi Baharu Tawan Peringkat Global

Disember 10, 2025
(SeaPRwire) - SHENZHEN, China, 10 Dis. 2025 — Dreame Technology memasuki pasaran TV mini LED global dengan siri Dreame TV melalui Shenzhen Televi Intelligent Technology Co., Ltd., sebuah perusahaan teknologi di bawah Dreame. Selepas kemunculan sulungnya di IFA Berlin dan ELLE POP – UP di Hungary, ia juga akan dipamerkan di CES. Setelah dilancarkan di Singapura dan negara-negara lain, siri ini dirancang untuk dikeluarkan di Emiriah Arab Bersatu pada bulan Disember, dan Malaysia juga dimasukkan ke dalam skema pelancaran. Siri Dreame TV S100 dan V3000 mempamerkan teknologi Aura Mini LED di Canton Fair ke-138, yang baru sahaja dirasmikan. S100 dipamerkan pada bulan November di pameran ELLE POP-UP utama di Budapest. S100 mempunyai lampu latar Aura Mini LED dengan pemudaran tempatan susunan penuh, memberikan kawalan cahaya yang tepat dan warna hitam yang dalam. Dengan kecerahan puncak 1000 nits dan teknologi QLED+ yang menghasilkan lebih 1.07 bilion warna, setiap butiran tajam dan setiap warna kelihatan hidup. Dikuasakan oleh pemproses AI Dreamind Pro tersuai, kandungan 2K dinaik taraf secara pintar hampir kepada 4K, dengan penalaan warna dan kejelasan adaptif untuk bingkai yang semula jadi dan hidup. Pada masa yang sama, S100 diintegrasikan dengan Dreame 4.1.2ch Master Sound System, dilengkapi dengan 11 unit bunyi yang meliputi julat frekuensi tinggi, sederhana, dan rendah, memberikan lapisan bunyi yang lebih lengkap. Kuasa puncak mencecah 70W, jauh lebih tinggi daripada output biasa 40W untuk TV arus perdana, memberikan tenaga panggung bunyi yang lebih mencukupi. Dengan liputan bunyi fizikal 270°, ia mencipta medan audio yang hampir menyelubungi seluruh ruang. S100 mempunyai sistem soundbar yang terintegrasi sepenuhnya, menjadikan pembelian televisyen ini dari segi fungsi setara dengan memiliki kedua-dua TV berdiri sendiri dan soundbar berasingan. V3000, flagship global Dreame, mempunyai "Black Crystal True Color Screen" dengan kadar pantulan hanya 1.8%, menghapuskan silau dalam persekitaran terang. Paparan Premium Aura Mini LEDnya menggabungkan teknologi QLED dan Mini LED, menyampaikan 1 bilion warna, liputan 98% DCI-P3, ketepatan warna ΔE≈0.7, dan kecerahan puncak 2800 nits. Prestasi permainan unggul dengan kadar segar semula 300Hz, ketinggalan input 5.3ms, dan sokongan untuk VRR, ALLM, dan AMD FreeSync Premium Pro. Sistem Bunyi Master Dreame 2.1.2ch bersepadu dengan Dolby Atmos® dilengkapi dengan subwoofer khusus dan reka bentuk dwi-horn. Ia menghasilkan liputan bunyi fizikal 270°, berbeza dengan bunyi sekeliling 360 darjah biasa yang dilaras oleh algoritma. Kami tidak sabar-sabar menantikan pelancaran V3000 di Emiriah Arab Bersatu, Singapura, dan Indonesia. Dreame TV telah mempamerkan projektor dan sistem audionya di IFA, dengan rancangan untuk dipamerkan di CES. Barisan produk termasuk projektor laser T2, menawarkan imej Full HD 120 inci dengan pembetulan automatik dan reka bentuk berkuasa bateri, serta model jarak lempar ultra-pendek T3 untuk skrin besar dari jarak minimum. Shenzhen Televi Intelligent Technology Co., Ltd. adalah sebuah perusahaan teknologi di bawah Dreame, yang berdedikasi untuk memajukan inovasi dalam teknologi audio-visual dan paparan rumah.Artikel ini disediakan oleh pembekal kandungan pihak ketiga. SeaPRwire (https://www.seaprwire.com/) tidak memberi sebarang waranti atau perwakilan berkaitan dengannya. Sektor: Top Story, Berita Harian SeaPRwire menyampaikan edaran siaran akhbar secara masa nyata untuk syarikat dan institusi, mencapai lebih daripada 6,500 kedai media, 86,000 penyunting dan wartawan, dan 3.5 juta desktop profesional di seluruh 90 negara. SeaPRwire menyokong pengedaran siaran akhbar dalam bahasa Inggeris, Korea, Jepun, Arab, Cina Ringkas, Cina Tradisional, Vietnam, Thai, Indonesia, Melayu, Jerman, Rusia, Perancis, Sepanyol, Portugis dan bahasa-bahasa lain.
More
Pengumuman Kandungan NYSE: Kemas Kini Pasaran + Target Membuka ‘Target SoHo’ Yang Ditransformasi Semula di New York Berita

Pengumuman Kandungan NYSE: Kemas Kini Pasaran + Target Membuka ‘Target SoHo’ Yang Ditransformasi Semula di New York

Disember 10, 2025
(SeaPRwire) - NEW YORK, 9 Dis 2025 — New York Stock Exchange (NYSE) menyediakan kemas kini pasaran harian terus dari Lantai Dagangan NYSE. Akses kemas kini pasaran NYSE hari ini untuk pandangan pasaran sebaik sahaja dagangan bermula. Kristen Scholer menyampaikan kemas kini pasaran pada 9 Disember Pedagang menunggu keputusan kadar faedah terakhir Federal Reserve untuk tahun ini. Pasaran telah menganggarkan dengan hampir pasti potongan kadar 0.25%, berikutan mesyuarat dasar dua hari Fed yang bermula hari ini, dengan pengumuman dijangka pada hari Rabu. Target yang tersenarai di NYSE melancarkan kedai SoHo yang direka semula dipimpin oleh CEO baharu Michael Fiddelke. Konsep ini termasuk bar kecantikan, daftar keluar selfie, dan koleksi rumah serta fesyen terpilih. Ashley Mastronardi dari NYSE berbual dengan Naib Presiden Kurasi Kreatif Target—tonton temu bual tersebut di aplikasi TV NYSE. Twenty One Capital tersenarai awam hari ini di NYSE di bawah ticker XXI, menjadi syarikat perbendaharaan Bitcoin terbesar di bursa dengan $4 bilion dalam Bitcoin. CEO Jack Mallers menyampaikan ucapan sebelum membunyikan Loceng Pembukaan. Loceng PembukaanTwenty One Capital (NYSE: XXI) meraikan IPO-nya Loceng PenutupAtlantic Union Bankshares (NYSE: AUB) meraikan hari pelaburannya Video – Logo – Artikel ini disediakan oleh pembekal kandungan pihak ketiga. SeaPRwire (https://www.seaprwire.com/) tidak memberi sebarang waranti atau perwakilan berkaitan dengannya. Sektor: Top Story, Berita Harian SeaPRwire menyampaikan edaran siaran akhbar secara masa nyata untuk syarikat dan institusi, mencapai lebih daripada 6,500 kedai media, 86,000 penyunting dan wartawan, dan 3.5 juta desktop profesional di seluruh 90 negara. SeaPRwire menyokong pengedaran siaran akhbar dalam bahasa Inggeris, Korea, Jepun, Arab, Cina Ringkas, Cina Tradisional, Vietnam, Thai, Indonesia, Melayu, Jerman, Rusia, Perancis, Sepanyol, Portugis dan bahasa-bahasa lain.
More